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SUMMARY
Multiple comparisons and selection procedures are commonly studied in research
and employed in application. Clinical trial is one of popular fields to which the
subject of multiple comparisons is extensively applied. Based on the Federal Food,
Drug, and Cosmetic Act, drug manufacturers need to not only demonstrate safety of
their drug products but also establish effectiveness by substantial evidence in order
to obtain marketing approval. However, the problem of error inflation occurs when
there are more than two groups to compare with at the same time. How to design a
test procedure with high power while controlling type I error becomes an important
issue.
The treatment with the largest population mean is considered to be the best one
in the study. Potentially the best treatments can receive increased resources and
further investigation by excluding clearly inferior treatments. Hence, a small number
of possibly the best treatments is preferred. This thesis focuses on the problem of
eliminating the less effective treatments among three in clinical trials. The goal is to
increase the ability to identify any inferior treatment providing that the probability of
excluding any best treatment is guaranteed to be less than or equal to α. A step-down
procedure is applied to solve the problem.
The general step-down procedure with fixed thresholds is conservative in our prob-
lem. The test is not efficient in rejecting the less effective treatments. We propose
two methods with sharper thresholds to improve current procedures and construct
a subset containing strictly inferior treatments. The first method, the restricted pa-
rameter space approach, is designed for the scenario when prior information about
xii
range of treatment means is known. The second method, the step-down procedure
with feedback, utilizes observations to modify the threshold and controls error rate
for the whole parameter space. The new procedures have greater ability to detect
more inferior treatments than the standard procedure. In addition, type I error is





The Federal Food, Drug, and Cosmetic Act was first passed by Congress back in
1938. The Act requested drug labels provide adequate direction for safe use. In
addition, it regulated drug manufacturers prove the safety of their products to the
U.S. Food and Drug Administration (FDA) before entering the market. With growing
concern about high drug prices and misleading or unsupported assertions made by
pharmaceutical companies regarding to their products, Congress amended the Act
and added a requirement for effectiveness in 1962.
The 1962 Drug Amendments contained a provision requiring manufacturers to
establish the effectiveness of their drug products by “substantial evidence” in order to
obtain marketing approval. Substantial evidence was defined in section 505(d) of the
Act as “evidence consisting of adequate and well-controlled investigations, including
clinical investigations, by experts qualified by scientific training and experience to
evaluate the effectiveness of the drug involved, on the basis of which it could fairly and
responsibly be concluded by such experts that the drug will have the effect it purports
or is represented to have under the conditions of use prescribed, recommended, or
suggested in the labeling or proposed labeling thereof.”[1] What components establish
sufficient evidence of effectiveness and how to demonstrate the evidence have became
1
a contentious issue since then.
The process of proving the evidence is usually costly and time consuming. To
a pharmaceutical company, the level of effectiveness is one of determinant elements
for whether investing a new drug. In terms of public health, it is important for the
government to set up regulations for drug development. Therefore, it is an essential
topic to research into efficient and sound methodologies for testing the efficacy of
treatments.
1.2 Introduction to clinical trials
A lot of resources have been allotted to the field of clinical trials. The National
Institutes of Health (NIH) had an actual funding of 2,767 million dollars in this field
in FY 2006. The funding level is estimated to be 2,764 and 2,756 million dollars in
FY 2007 and 2008 respectively.
A clinical trial is a research study which tests a treatment in human beings to see
whether it is both safe and effective to remedy a disease or a condition. Each trial
must follow a protocol which explains the intention, the necessity, and the plan of a
study. The clinical trials can provide researchers with information that helps them
better understand the diseases and compare the performance of the treatments under
different conditions. Clinical trials can be generally categorized as follows depending
on the aspects of medical care they serve.
• Treatment trials: Test treatments for specific diseases or conditions.
• Supportive care trials: Study methods to provide a certain group of subjects
2
with a better quality of life.
• Prevention trials: Reduce the risk of developing a disease for healthy people.
• Diagnostic trials: Test new ways to detect a disease earlier and more accu-
rately.
In clinical trials, there are mainly three types of comparisons: trials to show (1)
superiority, (2) equivalence or noninferiority, and (3) dose-response relationship. New
drugs are first tested in laboratories and then on animals. Since clinical trails involve
human beings, they are normally expensive and have strict requirements for safety.
Before carrying out a clinical trial, there needs to be strong evidence that the therapy
is secure to people and is most likely effective to patients. Typically, there are four
stages of clinical trials serving different purposes:
• Phase I:
A small group of people about 20 to 80 participate in the first phase. Researchers
test a new drug or treatment to evaluate its safety, determine a safe dosage
range, and identify side effects.
• Phase II:
A larger group of people around 100 to 300 are recruited in phase II. The
purpose of this stage includes checking whether the drug has effect against the
disease and further evaluating its safety.
• Phase III:
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An even larger group of people from 1,000 to 3,000 are involved in phase III.
But it can be as many as 10,000 patients. The study drug or treatment is
tested to confirm effectiveness, monitor side effects, compare with commonly
used treatments, and collect information that will allow it to be used safely.
• Phase IV:
Post-marketing study are implemented to gain addition information containing
the risks, benefits, and optimal use of a drug.
1.3 Introduction to multiple comparisons and selection pro-
cedures
Multiple comparisons and selection problems are a common topic in many fields. It
is ordinary to have more than two groups to compare with at the same time. For
example, test treatment effects or toxicity levels of a group of chemical compounds
in a dose-response study, analyze consumers’ preference for a series of products in
market surveys, and compare the yield rates from different systems or manufacturing
processes in a quality control study. One typical method to analyze these types of
questions is to apply ANOVA table with F test to examine homogeneity among the
groups. If the null hypothesis of homogeneity is rejected, however, ANOVA table does
not provide further information about which groups are statistically different. The
results of F test may not meet requirement. Therefore, researchers are interested in
investigating multiple comparisons or other methodologies which furnish them with
the relationships among the groups.
4
When comparing two population means, type I error is defined as the probability of
incorrectly rejecting the null hypothesis that two meas are equal. The error rate is set
to be protected at or below α. However, the problem of how to meet the probability
constraint becomes more complicated when there are more than two groups. Denote






tests with multiple pairs of null and alternative hypotheses. H0 : µi = µj
vs. Ha : µi = µj, 1 ≤ i, j ≤, k, i 6= j. The corresponding type I error is the
probability of incorrectly rejecting any null hypothesis which brings about the error
inflation problem. If the nominal error rate of an individual test is controlled at
α, the exact type I error rate of an all-pairwise comparison family set is actually
greater than α. For example, an all-pairwise comparison set has 6 tests in studying
four populations. Suppose that type I error of an individual test is maintained not
exceeding 5%. Then, the total error rate of six pairwise tests significantly increases
to 26.5%.
α′ = 1− (1− α)g, g is the total number of tests
The fact demonstrates the importance of the field in multiple comparisons and the
necessity of controlling α value when k ≥ 3. Statistical adjustments for multiplicity
are appropriate for controlling type I error.
The foundation of the field of multiple comparisons were established in late 1940s
and early 1950s. A few principal pioneers are Duncan, Roy, Scheffé, and Tukey.
Some similar ideas can be traced back to the earlier works by Fisher, Gossett, and
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others. Harter (1980)[18] has a detailed description about the early history in mul-
tiple comparisons. The books written by Miller (1966)[30] and by Hochberg and
Tamhane (1987)[25] provide comprehensive multiple comparisons procedures estab-
lished in their eras and point out new research directions in the field.
However, there has been abundant debate and controversy over the need for α
adjustment to take the multiplicity of inferences into consideration. The ideas can be
generally classified into three schools of thought:
• Familywise error rate
• Comparisonwise error rate
• Bayesian
The first school of thought led by Tukey (1953)[40] and Scheffé (1953)[36] adjusts
the error rate of each individual test. This school deems that it is essential to use
multiple comparisons methods which control familywise error rate to ensure that
the probability of having at least one false rejection of the null hypothesis does not
exceed α. The assigned familywise error rate or so called the experimentwise error
rate applies to all of the hypothesis tests in the family set as a whole instead of to
a single test. A list of related procedures using adjusted probability are discussed in
chapter 2.
On the other hand, many statisticians have opposite point of view on whether us-
ing statistical adjustments (e.g. O’Neill and Wetherill (1971)[32], Petersen (1977)[34],
Carmer and Walker (1982)[9], O’Brien (1983)[31], Perry (1986)[33], and Rothman
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(1990)[35]). Under this school of thought, each test or statistical inference is handled
one by one and the probability adjustment is not necessary. The probability of falsely
rejecting the null hypothesis of one single test is known to be the comparisonwise error
rate. This probability applies to each individual hypothesis test, but not collectively
as the familywise error rate.
The last school of thought employs Bayesian approach to access multiple compar-
isons problems. A few representative works such as Duncan (1965)[11], Waller and
Duncan (1969)[41], Duncan and Dixon (1983)[12] use prior distributions for unknown
parameters, linear loss functions for an individual test, and an additive loss function
for the entire loss.
1.4 Overview of the thesis
A test procedure is preferable if the number of potentially the best treatments selected
by the test is small and if the procedure can keep all the most effective treatments at
the end of the test as well. The procedure should protect the best treatments from
being discarded and prevent concluding too many inferior options as superior ones.
The objectives can be achieved from the other side by removing as many inferior
treatments as possible.
The goal of this research is to develop methodologies which possesses greater power
in detecting strictly inferior treatments while controlling the probability of making
an incorrect decision. The main ideas are to modify the critical values and to use
observations as feedback to improve the general step-down procedure with constant
7
thresholds.
The thesis is organized as follows. Chapter 2 reviews multiple comparisons and
selection procedures for the response with Normal distribution. Chapter 3 performs
a preliminary study including the setting and the properties of the problem. Chapter
4 studies the critical values for the step-down procedure under a restricted parameter
space which is a subset of the configurations when the range of treatment means is
bounded by a given number. Chapter 5 presents a step-down procedure with feedback
which employs observations to maintain type I error for the whole parameter space.
Chapter 6 simulates several parameter settings which violate the assumptions of the
step-down procedures studies in the thesis.
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CHAPTER II
LITERATURE REVIEW ON MULTIPLE COMPARISONS
AND SELECTION PROCEDURES FOR NORMAL
RESPONSE EXPERIMENTS
Three widely accepted formulation have been developed to approach multiple compar-
isons, screening, and selection problems: subset selection approach, Indifference-zone
approach, and the simultaneous confidence intervals approach. Subset selection ap-
proach is a screening scheme which determines a subset of the treatments including at
least one of the best ones. The size of the subset created is arbitrary. This approach
facilitates the analysis of the experiment when there are a random number of choices.
Indifference-zone approach which chooses the best treatments is concerned more with
the design of an experiment. In addition to comparing treatments, this methodology
develops the scale of an experiment in order to meet the probability requirements in
advance. Finally, the simultaneous confidence intervals approach specifies the differ-
ences between treatment means. The confidence intervals quantify the magnitudes of
discrepancies and control the familywise error rate. The following two books provide
the details of these approaches. The first book written by Gibbons, Olkin, and Sobel
(1977)[16] describes the procedures clearly and provides a large number of useful ta-
bles for implementation. As for the second book written by Bechhofer, Santner, and
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Goldsman (1995)[7], it discusses sequential procedures and subset selection formu-
lations more extensively than the first book. If available, the second book provides
several options for the same problem and makes recommendations about different
alternatives. It assumes that readers are knowledgeable about standard experimental
designs. Below is the summary of the three approaches for multiple comparisons and
selection problems.
2.1 Subset selection approach
Subset selection is an approach that constructs a random size subset of interested
elements. The procedure screens multiple alternatives and selects the desirable op-
tions for each question. Gupta (1956)[17] who was a pioneer in this field proposed a
single-stage procedure which creates a subset containing the best treatment when it is
unique. If there are two or more the best treatments, Gupta’s procedure guarantees
that at least one of the best treatments are chosen. Denote k as total number of
treatments, n as sample size of each treatment, ν as degree of freedom, α as fami-
lywise error rate, x̄i as the sample mean from treatment i, and s
2 as pooled sample
variance. Suppose that the treatment with a larger mean is considered to be a more
effective therapy, the procedure is to select treatment i into the subset if and only if
x̄i ≥ max{x̄j, 1 ≤ j ≤ k} − dk−1, ν, α s√
2/n
.
dk−1, ν, α is a predetermined value which controls type I error rate at α. The idea of
the procedure is that if a treatment has a sample mean not too far away from the
maximum, the associated treatment is perhaps the best one and then is chosen into
10
the subset.
Gupta’s method, however, does not assure that all of the best treatments are
selected when there exists several superior treatments. Consequently, removing the
treatments in the complement of the subset created may delete both the worse and
the best treatments. In contrast, the new methodologies proposed in this study have
the ability to construct a subset that contains inferior treatments only which cannot
be achieved by Gupta’s method.
Selection procedures can be separated into two categories depending on whether
the order of hypothesis testing influences the conclusion. First, the single-step proce-
dures are independent on test order. The decision for any hypothesis Hi does not rely
on any other hypothesis Hj, i 6= j. Each hypothesis testing can be carried out indi-
vidually without being affected by the other tests. On the contrary, the order of the
hypotheses is influential to the stepwise procedures. The decisions of the hypotheses
in the former steps may affect the decisions of those hypotheses tested later. The
order of the tests is ordinarily decided by the magnitude of test statistics or p-values.
2.1.1 The single-step procedures
Bonferroni procedure is a popular single-step procedure which controls the family-
wise error rate in the strong sense. The strong control (see Hochberg and Tamhane
(1987)[25]) means that the probability of making any type I error of all configurations





t tests at level α′ = α
(k2)
for each test. Any individual hypothesis Hi is rejected if the
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corresponding p-value, pi, is less than α






. The procedure becomes conservative as g increases which can be

















Bonferroni procedure insures that the overall type I error is less than or equal to α if
an individual test has a significance level of α
g
when simultaneously testing g pairwise
comparisons.
Tukey method can also be considered as a single-step procedure in subset selec-
tion. The technique proposed by Tukey will be illustrated in detail later on in section
2.3, the simultaneous confidence intervals approach. These single-step procedures
equally treat every hypothesis without taking test order into account.
2.1.2 The stepwise procedures
Stepwise procedures can further be divided into the step-down procedures, the step-
up procedures, and the step-up-down procedures. The distinction is the order of the
test with which it starts. The step-down procedure first examines the most signifi-
cant hypothesis while the step-up procedure first tests the least significant one. The
properties and the related literature of these three types of procedures are addressed
in the following subsections.
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2.1.2.1 The step-down procedures
A step-down procedure begins with testing the most significant hypothesis with the
largest test statistics or the smallest p-value. The stopping rule is to continue until a
hypothesis is not rejected. All of the remaining hypotheses are then accepted without
further tests by implication. Typically, this type of procedures use a non-increasing
sequence of critical values for successive test steps.
The idea of the step-down procedure can be traced back to the book by Miller
(1966)[30]. The article, however, does not provide a proof nor mention the property
of controlling the familywise error rate in a strong way. A general method for con-
structing a step-down test procedure was proposed by Marcus, Peritz, and Gabriel
(1976)[29]. Their method is referred to as a closure method and can be used to form
an α-level multiple test procedure. The closure method is a technique that constructs
tests where the probability of making at least one incorrect assertion is under control.
And a procedure is said to be an α-level multiple test procedure if it can meet the
strong control condition regardless of how many hypotheses are true or false.
Holm (1979)[26] presented a p-value based step-down procedure which improves
the power of Bonferroni procedure. The p-values are first ordered as p(1) ≤ p(2) ≤
· · · ≤ p(g) with associated hypotheses H(1), H(2), · · · , H(g). The procedure begins with
testing the most significant hypothesis, H(1), and continues in order until an accep-
tance occurs. H(i) is rejected in the i
th step if p(i) ≤ αg−i+1 , 1 ≤ i < g. Otherwise, the
procedure is stopped and accept all of the H(j) where j ≥ i. The probability criteria
are no longer fixed numbers like those in Bonferroni procedure but are dependent on
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the sequence of the tests.
Broström (1981)[8] and Finner & Giani (1994)[14] proposed general step-down
procedures which choose a subset of the treatments with population means smaller
than the maximum by ε, ε > 0. When ε equals zero, Hayter (2007)[23] suggested
sharper critical values and provided confidence intervals for the differences in means.
2.1.2.2 The step-up procedures
The order of the step-up procedures is opposite to that of the step-down procedures. A
step-up procedure starts with testing the least significant hypothesis with the smallest
test statistics or the largest p-value. The termination rule is to stop the procedure
when a hypothesis is rejected. Then, the rest of the hypotheses are rejected by
implication without further tests. A hypothesis testing, Hm with a p-value of p(m),
is performed if and only if all of the hypotheses whose p-values are greater than or
equal to p(m) are all retained. The step-up procedure frequently uses a non-decreasing
sequence of critical values in the test procedure.
Welsch (1977)[42] mentioned a step-up procedure based on the studentized range
statistics for one-way layouts. His method achieve strong control over the familywise
error rate. Dunnett and Tamhane (1992)[13] proposed a step-up multiple test proce-
dure which compares test statistics with certain critical points. The procedure can
be applied to test a nonhierarchical family of hypotheses with two or more contrasts.
Hochberg (1988)[24] came up with a p-value based step-up procedure. The proce-
dure starts the sequential tests with the least significant hypothesis with the largest
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p-value and continues in order until a rejection happens. Similarly, the p-values
are first ordered as p(1) ≤ p(2) ≤ · · · ≤ p(g) with the corresponding hypotheses
H(1), H(2), · · · , H(g). In step 1, suppose that p(g) > α, the associated hypothesis
H(g) is accepted and proceed to testing H(g−1). In the ith step, H(g−i+1) is accepted
if p(g−i+1) > αi , 1 ≤ i < g. Otherwise, the procedure is stopped and reject all
of the H(j) where j ≤ g − i + 1. Although the algorithm of Hochberg’s step-up
procedure is inverse, the procedure uses the same critical values as those in Holm’s
procedure. Therefore, Hochberg’s step-up procedure always rejects any hypothesis
rejected by Holm’s step-down procedure. Hochberg’s procedure uniformly dominates
Holm’s procedure in terms of having greater power.
2.1.2.3 The step-up-down procedures
The step-up procedures which begin with testing the minimum statistics is called as a
MIN test in Laska and Meisner (1989)[28]. This type of approached concerns whether
all of the hypotheses can be rejected. If not, the step-up procedures offer advanced
information to identify the acceptable hypotheses. Based on the same concept, the
step-down procedures which begin with examining the maximum statistics can be
called as a MAX test. The main interest of the procedures is to check whether at
least one of the hypotheses can be rejected or not. If the answer is positive, the step-
down procedures continue a further study to recognize the rejectable hypotheses.
A more general issue than the topics discussed in the previous two procedures is
that “whether at least q hypotheses can be rejected” where q is a number between
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1 and the total number of hypotheses, g. This issue is addressed by Tamhane, Liu,
and Dunnett (1998)[39]. Denote the ordered test statistics as t(1) ≤ t(2) ≤ · · · ≤ t(g)
with associated hypotheses H(1), H(2), · · · , H(g). Let r = g + 1 − q. In the first
step, if t(r) ≤ cr, accept H(1), H(2), · · · , H(r) and continue with the step-up procedure;
otherwise, reject H(r), H(r+1), · · · , H(g) and continue with the step-down procedure.
It is apparent that the step-up procedure and the step-down procedure are special
cases of the step-up-down procedure when q = g and q = 1 respectively.
In general, a single-step procedure has advantages of easy to execute the test
procedure, easy to quantify the discrepancy between population means, and easy to
construct confidence intervals. However, the power of the test procedure is not very
satisfying. On the other hand, the stepwise procedures may make up for power via
carrying out more steps. But, it is cumbersome to calculate the critical values in each
step. This problem becomes less severe as the development of computers. Which test
procedure should a experimenter choose depends on the definition of an error decision
and the power of a test. If the power improvement can compensate the work for more
complicated procedures, it would be better to use the stepwise procedures.
2.2 Indifference-Zone approach
Indifference-zone approach can be applied to selection problems and can allow a more
practical purpose. Two treatments are said to be indifferent when the difference of
the associated means is below a certain threshold, δ∗. δ∗ is closely connected with the
sample size and the required probability of correct selection. Restricted by the issues
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such as budget considerations and accuracy rate, the threshold can be considered to
be the worthwhile level for detection. For example, drug safety is very important
to public health and is strictly regulated by the government. In addition to having
significant efficacy against the diseases or the conditions, toxicity level and the other
side effects of the drugs are required to be at a low level. A minor increase in toxicity
level may cause serious danger to patients. In this case, researchers may prefer setting
δ∗ small. Consequently, the experiment requires a larger amount of samples in order
to meet the predetermined probability requirement for correction selection.
Bechhofer (1954)[3] proposed a single-stage Indifference-zone procedure which se-
lects the treatment associated with the largest sample mean as the best one in a
completely randomized design. One disadvantage of his approach is that the proce-
dure can identify only one best treatment even though there may exist several equally
effective treatments. Besides, Bechohofer’s single-stage Indifference-zone approach is
found to be conservative. The procedure sometimes requests a large sample size
which is unaffordable for an experimenter under a certain δ∗ value and a probability
requirement.
The multi-stage or sequential procedures can compensate the problem of a large
sample size to construct an affordable design. The main idea is to use the data
obtained in the former stages to speculate the true setting of population means. One
simple approach is called a closed two-stage procedure with elimination introduce by
Cohen (1959)[10], Alam (1970)[2], and Tamhane and Bechhofer (1977, 1979)[37, 38].
A procedure is closed if there is a fixed upper bound on the number of observations
to be taken from each population before carrying out an experiment. Otherwise, it is
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open. The procedure is said to be eliminating if the data taken in the previous stages
can be used to exclude populations from further sampling and consideration.
There are many other literature related to Indifference-zone approach. For ex-
ample, a closed multi-stage procedure without elimination studied by Bechhofer and
Goldsman (1987, 1989)[5, 6]. As for the common but unknown variance case, see
Bechhofer, Dunnett and Sobel (1954)[4] for an open two-stage procedure without
elimination and Hartmann (1991)[19] for an open multi-stage procedure with elimina-
tion. Generally speaking, the multi-stage procedure is preferable over the single-stage
procedure in terms of having smaller expected total number of observations used by
the procedure.
2.3 The simultaneous confidence intervals approach
The multiple comparisons and the selection problems can also be addressed by formu-
lating a set of simultaneous confidence intervals for the differences between treatment
means. The simultaneous confidence intervals approach controls the overall error rate
where the confidence intervals jointly cover every comparison at a given level α. A
confidence interval is more informative than a hypothesis testing for it gives extra
message about the magnitude of the differences. Applying simultaneous confidence
intervals can lead to the same information as those from a hypothesis testing but not
vice versa. For example, containing number zero inside the confidence interval of the
discrepancy in population mean implies that the two treatment means are not sta-
tistically different. Meanwhile, the null hypothesis of H0 : µi = µj, i 6= j cannot be
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rejected either. Conversely, if such a null hypothesis is rejected, a hypothesis testing
does not quantify the difference of the two population means which is provided by
confidence intervals.
Tukey provided the studentized range critical point, qk, α, ν , for all-pairwise com-
parisons with k population means.
µi − µj ∈
[
x̄i − x̄j − qk, α, ν s√
n
, x̄i − x̄j + qk, α, ν s√
n
]
, 1 ≤ i, j ≤ k, i 6= j
If the common variance is known, the degree of freedom ν = ∞. If not, ν =







a balance design where ni = n, 1 ≤ i ≤ k, qk, α, ν guarantees that the probability of
rejecting the null hypothesis of H0 : µ1 = µ2 = · · · = µk is exactly α when H0 is
true. The simultaneous confidence intervals control the familywise error rate at α.
The procedure is sometimes referred as the honestly significant difference (HSD)
in the literature. Gabriel (1969)[15] showed that Tukey’s method offers the tightest
intervals for all-pairwise comparisons among all of the procedures which give equal-
length intervals in a balanced one-way layout. As for an unbalanced design, Hayter
(1984)[21] proved that Tukey’s procedure is conservative. Type I error is less than or
equal to α.
Beside two-sided confidence intervals, one-sided confidence intervals are more use-
ful to special cases. Suppose that the underlying configuration has an ordered rela-
tionship of µ1 ≤ µ2 ≤ · · · ≤ µk. Then, it is more interesting to construct one-sided
confidence intervals with lower bounds on µi−µj for all i > j. For instance, it is well
known that toxicity level increases as the amount of a dose raises. One application
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of the one-sided simultaneous confidence intervals is to study the toxicity level at
different dose levels. Hayter (1990)[22] derived the simultaneous confidence intervals
with lower bounds and tabulated the critical values for k ≤ 9 cases. If µi’s have
indeed an ascending order as mentioned, the procedure using one-sided simultaneous
confidence intervals is more competent in detecting the difference between treatment
means than the procedure using two-sided simultaneous confidence intervals. When
comparing three ordered treatment means of µ1 ≤ µ2 ≤ µ3, Hayter, Miwa, and Liu
(2001)[20] gave sharper critical values and presented a more efficient procedure which
considers directional discrepancy while providing two-sided confidence intervals. A




BACKGROUND INFORMATION OF THE PROBLEM
3.1 Introduction
Suppose there are k populations having independent normal distributions N(µi, σ
2),
1 ≤ i ≤ k. The common variance, σ2, can be either known or unknown. And the
unknown parameter of interest is the location parameter, µ, which is preferred to be
large. The treatment possessing the maximum mean value among k treatments is
considered as the most effective therapy while the rest are regarded as inferior ones.
The best treatment may not be unique. The problem studied in this research is how
to set up an efficient procedure to discriminate the worse treatment from the best
ones in a balanced design. Specifically, the thesis concentrates on the modification of
the step-down procedures which eliminate one treatment at a time.
A step-down procedure categorizes populations into either the non-best subset
(NB) or the best subset (NBc) based on its own guideline. A test procedure is
efficient if it can narrow down the number of the treatments which possibly have high
efficacy when the performance of treatments is unknown. It is favorable to construct
a small NBc subset or say a large NB subset. However, if the NBc is too small,
the test procedure may exclude actually the best treatments. The problem caused by
eliminating possibly the best treatments is more serious than concluding a big group
of candidates in this study. So, the objective of the research is stated as:
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minimize |NBc| (or maximize |NB|)
subject to P (population j ∈ NB| population j is the best) ≤ α
This study improves the existing step-down procedure to be more efficient in de-
tecting and eliminating inferior treatments. The sharper critical values offered in
chapter 4 and a new step-down procedure with feedback introduced in chapter 5
make the general approach less conservative. The new methodologies not only con-
trol the familywise error rate but also eliminate more inferior treatments. The case
of comparing three treatments, k = 3, is focused in the whole study.
3.1.1 Notation
• Ti: ith population, 1 ≤ i ≤ 3
• µi: location parameter, population mean of Ti, 1 ≤ i ≤ 3
• µ(i): ordered population mean, µ(1) ≤ µ(2) ≤ µ(3)
• σ2: common population variance
• n: sample size from each population
• ν: degree of freedom
• Xij: jth observation of population i, Xij indep∼ N(µi, σ2), 1 ≤ i ≤ 3
• X̄i: sample mean of population i, X̄i indep∼ N(µi, σ2n ), 1 ≤ i ≤ 3
• X̄(i): ordered sample mean, X̄(1) ≤ X̄(2) ≤ X̄(3)
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, 1) = N(µ∗i , 1), 1 ≤ i ≤ 3
• Y(i): ordered random variable with µ∗(1) ≤ µ∗(2) ≤ µ∗(3)
• S2: pooled sample variance
• U : random variable U = S
σ










), 0 < u < ∞
• d3 and d2: thresholds in the first and the second step of the step-down procedure
respectively, d2 < d3
• φ and Φ: pdf and cdf of a standard normal distribution
• B: a subset containing the true best treatments in the parameter space
• NB: a subset containing the inferior treatments in the decision space
3.1.2 Definitions
• Best treatment: The treatment with µi = max{µ1, µ2, µ3} = µ∗. There may
be more than one best treatments.
• Inferior treatment: The treatment with µi < µ∗. There may be more than one
inferior treatments.
• Error: An error decision is to select Ti into NB while µi = µ∗.
• Power: The power of the test is the ability of selecting Ti into NB while µi < µ∗.
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3.1.3 Parameter space
When k = 3, the relationship among three treatment means can be classified as
(1) µ(1) = µ(2) = µ(3) with |B| = 3, (2) µ(1) < µ(2) = µ(3) with |B| = 2, or (3) µ(1) ≤
µ(2) < µ(3) with |B| = 1 depending on the total number of best treatments. In case
(1), three treatments perform equally; in case (2), two treatments associated with
µ(2) and µ(3) are equally the best; in case (3), only the treatment corresponding to
µ(3) is the most effective one.
Assume that the common variance is 1 for simplicity. In order to present three








are used for x and y-axis respectively. The coordinates take the difference of treat-
ment means divided by the standard deviation of the contrasts. In this way, the
parameter space is symmetric shown in Figure 3.1. The center point (0, 0) indicates
case (1) with three equally the best treatments. Three solid lines represents case (2)
having two best treatments. And the rest of the area stands for case (3) when only
one maximum mean exists.
Every parameter setting can be matched to either of the three relationship types.
Under the aforementioned definition of error, the subsequent incorrect decision of each
relationship type should be handled individually. In case (1) when the configuration
maps to the origin point in the parameter space, an error decision is to claim any
treatment as inferior. If the true setting has a point locating on the solid line in the
parameter space like case (2), it is incorrect to eliminate the treatment or treatments
associated with µ(2), µ(3) or both. Last, when case (3): µ(1) ≤ µ(2) < µ(3) occurs,
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Figure 3.1: Parameter space.
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an error decision is to select the treatment with µ(3) into the NB subset. In conse-
quence, the probability of making an incorrect decision, P (error), has three different
formats depending on to which relation type a parameter configuration belongs. Since
the true structure of treatment means is unknown, the test procedures must control
P (error) for all µ settings in the whole parameter space.
3.2 Procedures
3.2.1 General step-down procedure
A step-down procedure is an approach which starts with testing the most significant
hypothesis and continues sequentially as long as a rejection occurs. The general way
to carry out a step-down procedure is to use a constant threshold, di, at each stage.
The values of di’s are predetermined so that the familywise error rate is controlled
at or below α. Suppose that there are k treatments. The testing hypotheses of step
i are H0(j) : µj = µ
∗, Tj is the best treatment vs. Ha(j) : µj < µ
∗, Tj is not the
best treatment where X̄j = X̄(i). Population j with X̄(j) is eliminated in step j if
X̄(k) − X̄(i) > dk−i+1, for all 1 ≤ i ≤ j < k. The threshold gets tighter from step to
step, dk > dk−1 > · · · > d2. When k = 3, it is a two-step step-down procedure. The
procedure takes up to two phases to separate all of the treatments into the NB and
the NBc subsets. The detailed general step-down procedure for the known variance
scenario is explained as follows.
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[Step 1]
Compare the difference between the maximum and the minimum standardized










> d3, remove Ti corresponding to X̄(1) into NB and continue
to Step 2.
[Step 2]
Compare the difference between the maximum and the median standardized











> d2, remove Tj corresponding to X̄(2) into NB. NB = {Ti, Tj}
where X̄i = X̄(1) and X̄j = X̄(2). Terminate the test procedure.
If variance is not given, σ is substituted with pooled sample standard deviation, S.
And the values for d2 and d3 when variance is known are different from those when
variance is unknown.
For example, suppose that σ√
n
= 1. If observing example (a) in Figure 3.2, the
range of the sample means is shorter than d3. So, stop the test procedure without
rejecting any treatment, NB = {φ}. Suppose that the relative location of the sample
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means is similar to example (b), treatment 1 is eliminated in the first step due to the
range of the sample means is greater than d3. However, the difference between X̄2
and X̄3 is not statistically large enough to discard treatment 2 in the second step of
the procedure. As a result, only treatment 1 is selected into the NB subset. As for
example (c), both X̄3− X̄1 and X̄3− X̄2 are greater than the thresholds in step 1 and
2 respectively. Therefore, treatment 1 is eliminated in the first step and treatment 2
is eliminated in the second step of the step-down procedure.
Figure 3.2: Examples of the general step-down procedure when k = 3.
3.2.2 Decision space under constant d2
There are seven possible outcomes after applying the general step-down procedure
introduced in the previous subsection when comparing three treatments. NB can be
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{φ}, {T1}, {T2}, {T3}, {T1, T2}, {T1, T3}, or {T2, T3} which represents for the
conclusion when no treatment is selected into NB, only treatment 1 is identified as
an inferior treatment, · · · , or both treatment 2 and 3 are claimed not to be the best
treatments. These outcomes divide the decision space into seven subspaces whose
shapes rely on the values of the two thresholds and the coordinates. For simplicity,
assume that σ√
n
is known to be 1. Figure 3.3 displays the decision space when the










The range of the sample means is less than or equal to d3 in step 1 if the observed
sample means have a matching point inside the hexagon, area (i), of the decision
space. Then, the resulting decision is to select no treatment into NB subset. Sim-
ilarly, any point in the region (ii) of the decision space satisfies
{
X̄1 < X̄2 − d3 and




X̄1 < X̄3 − d3 and X̄3 − d2 ≤ X̄2 ≤ X̄3
}
. The observations
lead to the conclusion of eliminating treatment 1 in the first step but removing no
element in the second step. If attaining a point lies within the area (iii) of the decision
space, it means that
{




X̄3 < X̄2 − d3 and
X̄3 ≤ X̄1 < X̄2 − d2
}
. Therefore, the conclusion is to put both treatment 1 and 3 into
NB by using the step-down procedure. The rest of the subspaces can be explained
by extending the same idea of relative locations of sample means.
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Figure 3.3: Decision space.
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3.3 Construction of error rate
How to decide the values for d2 and d3 then becomes an critical issue. The fact is that
these two thresholds cannot be arbitrary numbers due to the restriction on the error
decision rate. If the thresholds are overly short, the general step-down procedure will
end up with rejecting too many hypotheses than it should. Some of the most effective
treatments may be eliminated as well. The probably of rejecting a best treatment
gets out of control in such a case. Therefore, the condition of P (error) ≤ α confines
the lower bounds of d2 and d3. Next, several parameter settings are discussed indi-
vidually to study the reasonable values for these two thresholds. Again, the following
discussion assumes that σ√
n
= 1.
3.3.1 The setting with three equal means: µ1 = µ2 = µ3
First, the condition for the relationship type of three equal population means needs to
be satisfied. In order not to make an error decision under this type of configuration,
the range of the sample means should be less than or equal to d3 in step 1 of the test
procedure. Only in this situation that the procedure will stop without eliminating any
treatment. The case like Figure 3.4 which results in a wrong conclusion is undesirable.
Figure 3.4: One case which leads to an error decision if µ1 = µ2 = µ3.
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It infers that the size of the hexagon in the decision space cannot be too small.
Otherwise, the probability of getting NB = {φ} is less than 1−α which is the same as
having type I error greater than α. As a result, Pµ1=µ2=µ3(error) is a function of d3.
The critical value of d3 can be minimized and solved by setting Pµ1=µ2=µ3(error) = α.
The formulation is as below.
Pµ1=µ2=µ3(error)
= P (max {X̄1, X̄2, X̄3} −min {X̄1, X̄2, X̄3} > d3)




P (max {|Zi − Zj|, 1 ≤ i, j ≤ 3} ≤ d3|Zk = min {Z1, Z2, Z3})








φ(z) [Φ(z + d3)− Φ(z)]2 dz
= α (3.1)
Tukey[40] proposed studentized range statistics, qk, α, ν back to 1953. When vari-
ance is known, q3, α, ∞ exactly solves the equation (3.1). Tukey’s method guarantees
that the familywise error rate of testing H0 : µi = µj vs. Ha : µi 6= µj for all
1 ≤ i ≤ k, 1 ≤ j ≤ k, i 6= j is exactly α in a balanced design, and is less than or
equal to α in an unbalanced design see Hayter (1984)[21]. Thus, using d3 = q3, α, ν
controls the probability of rejecting the null hypothesis of H0 : µ1 = µ2 = µ3 is at or
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below α when the statement is actually true.
3.3.2 The setting with two best means: µ1 < µ2 = µ3
Second, the condition needs to be assured when there exists two best treatments in
a k = 3 case. Suppose that µ1 < µ2 = µ3. A decision is incorrect to claim that
treatment 2, 3, or both are inferior treatments in stage 1, 2, or both. The foregoing
step-down procedure will make improper conclusion if observing the examples shown
in Figure 3.5.
Figure 3.5: Three cases which lead to error decisions if µ1 < µ2 = µ3.
The probabilities of concluding NB = {T2}, {T3}, {T1, T2}, {T1, T3}, and {T2, T3}
all contribute to P (error) under this type of parameter relationship. These five out-
comes reject either one or two treatments. Consequently, the thresholds used in both
steps of the test procedure are influential. Pµ1<µ2=µ3(error) is a function of d3 and
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d2. Appropriate d2 and d3 should be chose so that the probability of getting a point
inside region (iii) to (vii) of the decision space is at or below α.
Pµ1<µ2=µ3(error)
= P (X̄2, X̄3 < X̄1, min {X̄2, X̄3} < X̄1 − d3)
+ P (X̄1 < X̄2, X̄3 < X̄2 − d3)
+ P (X̄1 < X̄3, X̄2 < X̄3 − d3)
+ P (X̄1 < X̄2 − d3, X̄2 − d3 ≤ X̄3 < X̄2 − d2)

















φ(x2 − µ2)Φ(x2 − d3 − µ1)
× [Φ(x2 − d2 − µ3)− Φ(x2 − d3 − µ3)] dx2
≤ α (3.2)
3.3.3 The setting with one best mean: µ1 ≤ µ2 < µ3
Similarly, both thresholds are influential in satisfying the probability constraint for
the parameter relationship with only one best treatment. Assume that µ1 ≤ µ2 < µ3,
it is an error to put treatment 3 into NB in either step 1 or 2 of the step-down
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procedure. The examples can be found in Figure 3.6.
Figure 3.6: Two cases which lead to error decisions if µ1 ≤ µ2 < µ3.
NB = {T3}, {T1, T3}, and {T2, T3} are all error decisions for this type of
parameter relationship. The chance of locating a point in region (iii) to (v) of the
decision space should be controlled at or below α. Therefore, Pµ1≤µ2<µ3(error) is a
function of d2 and d3, too.
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Pµ1≤µ2<µ3(error)
= P (X̄3 < min {X̄1, X̄2}, X̄3 < max {X̄1, X̄2} − d3)
+ P (X̄1 < X̄2 − d3, X̄1 < X̄3 < X̄2 − d2)
+ P (X̄2 < X̄1 − d3, X̄2 < X̄3 < X̄1 − d2)
= P (X̄1 ≥ X̄3, X̄2 ≥ X̄3)− P (X̄3 ≤ X̄i ≤ X̄3 + d3, i = 1, 2)
+ P (X̄1 < X̄3 < X̄2 − d3) + P (X̄1 < X̄2 − d3, X̄2 − d3 ≤ X̄3 < X̄2 − d2)




φ(x3 − µ3){[1− Φ(x3 − µ1)][1− Φ(x3 − µ2)]
















φ(x1 − µ1)Φ(x1 − d3 − µ2)[Φ(x1 − d2 − µ3)− Φ(x1 − d3 − µ3)] dx1
≤ α (3.3)
Consider the following extreme scenario when µ1 ¿ µ2 = µ3. Since the population
mean of treatment 1 is far below the other two populations means, the observations
from treatment 1 tend to be much smaller than those from treatment 2 or 3. Conse-
quently, treatment 1 is almost surely rejected and detected as an inferior treatment
in the first step of the test procedure. The judgment of step 1 is correct without
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doubt and the test procedure can easily exclude treatment 1. The key issue then
becomes how to determine d2 such that neither treatment 2 nor 3 is eliminated in the
second stage of the step-down procedure. This question is the same as comparing two
population means which can be solved by z test or t test. The asymptotic value of d2
turns out to be zα/2 when variance is known and tα/2, ν when variance is unknown.
The value of d2 must converge to these two statistics to maintain the error rate at
or below α for such an extreme parameter setting in the whole parameter space, for
example, (µ1, µ2, µ3) = (10
−6, 106, 106).
There are several ways to construct P (error) for each type of parameter set-
ting. The advantage of formulating the three P (error)’s as mentioned is to have
only one integral involved. The formulations of Pµ1=µ2=µ3(error), Pµ1<µ2=µ3(error),
and Pµ1≤µ2<µ3(error) are based on the relative location of sample means. Single
integration is actually enough to describe the circumstance of making an incorrect
decision. With less integration, the numerical calculation can be done faster and
more accurately. Figure 3.7 shows the numerical results of P (error) in one part of
the parameter space: µ1 ≤ µ2 ≤ µ3. The rest of the parameter space in other orders
can be extended by the symmetry property. The values for d3 and d2 used in the
graph are q3, 0.05, ∞ and d2 =
√
2zα/2 respectively. As it can be seen, the error rate is
at or below 5% for the whole parameter space.
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3.4 Properties of error rate
The goal of this research is to retrieve a small subset of potentially the best treat-
ments by eliminating less effective ones. The treatments selected into NB are then
excluded from further study. As a result, it is crucial to discard any possibly the best
treatment during the step-down procedure. The appropriate way is to put only the
definitely worse treatments into the NB subset. That is, type I error which is the
probability of including any best treatment into NB should be protected. As men-
tioned in the previous section, the way to construct type I error depends on the size of
the subset B. Different relationships of treatment means are associated with different
forms of P (error): Pµ(1)=µ(2)=µ(3)(error), Pµ(1)<µ(2)=µ(3)(error), Pµ(1)≤µ(2)<µ(3)(error).
This section discusses the properties of these P (error)’s when variance is known.
Same properties can be attained for the unknown variance case by taking the random
variable, S
σ
, into account. To simply notation, the ordered means of µ1 ≤ µ2 ≤ µ3 is
used. At the end of this section, an important conclusion about the most determinant
parameter configuration to the value of d2 will be made based on the three properties.
Chapter 4 and 5 intensively adopt the concepts presented in this section.
Property I.
Lemma 1. Pµ1≤µ2<µ3(error) is a decreasing function in δ where δ = µ3 − µ2 > 0.
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= P (T3 ∈ NB)

















































































Since φ(·) and Φ(·) are both non-negative functions with Φ(a) ≥ Φ(b) for a ≥ b,
the last four terms in the proof are all non-negative. Since Φ(−δ) is a monotonic
decreasing function with respect to δ, Pµ1≤µ2<µ3(error) decreases in δ. When the
smallest two population means are fixed, the probability of selecting the most effec-
tive treatment into NB diminishes as µ(3) gets away from µ(1) and µ(2).
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Property II.
Lemma 2. Pµ1≤µ2=µ3(error) is bigger than limδ→0 Pµ1≤µ2<µ3(error) where δ = µ3 −
µ2.






= P (treatment 2, 3, or both is selected into NB|δ = 0)
− lim
δ→0
P (treatment 3 is selected into NB|δ)
= P (NB = {T2}, {T3}, {T1, T2}, {T1, T3}, or {T2, T3}|δ = 0)
− lim
δ→0
P (NB = {T3}, {T1, T3}, or {T2, T3}|δ)
= P (NB = {T2} or {T1, T2}|δ = 0)
= P (X̄1 < X̄3 − d3 σ√
n
, X̄2 < X̄3 − d2 σ√
n
|δ = 0)
+P (X̄2 < X̄3 − d3 σ√
n
, X̄3 − d3 σ√
n
≤ X̄1 < X̄3|δ = 0)
+P (X̄2 < X̄1 − d3 σ√
n
, X̄1 − d2 σ√
n


















= P (at least one of the treatments are selected into NB|δ = 0)
− lim
δ→0
P (treatment 3 is selected into NB|δ)
= P (NB = {T1} {T2} or {T1, T2}|δ = 0) > 0
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The equations of the error rates follow different forms when the parameter con-
figurations have distinct sizes of B. Based on the definition of an error decision, more
types of the conclusions account for P (error) when |B| is bigger. If the true pa-
rameter setting has a large amount of the best treatments, it is easy to select any
of the most effective treatments into NB. Therefore, Pµ1<µ2=µ3(error) with |B| = 2
dominates the limiting probability of Pµ1<µ2<µ3(error) with |B| = 1; Pµ1=µ2=µ3(error)
with |B| = 3 dominates the limiting probability of Pµ1=µ2<µ3(error) with |B| = 1.
Property III.
The computational result demonstrates that Pµ1<µ2=µ3(error) is less than or equal
to α when using d2 =
√
2zα/2 and d3 = q3, α, ∞ for the known variance case; d2 =
√
2tα/2, ν and d3 = q3, α, ν , for the unknown variance case. Specifically, Pµ1≤µ2=µ3(error)
curve converges to α as treatment range goes to infinity.
3.5 Summary
Considering property I, II, and III all together leads to an important conclusion that
the configuration of µ(1) < µ(2) = µ(3) is critical in determining the values of d2
when comparing three treatments. By setting d3 to q3, α, ν and d2 to a constant, the
scenario with two best treatments has higher decision error rate compared with the
rest of the configurations except for the parameter setting with three equal means.
Pµ1=µ2=µ3(error) is exactly α when d3 = q3, α, ν . Assume that µ2 = µ3 = µ1+ε, ε ≥ 0.
Property I and II suggest that if Pµ1≤µ2=µ3(error) ≤ α, then P (error) is maintained
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Figure 3.10: Property III of P (error)
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at or below α for all of the parameter settings where 0 ≤ µ2 − µ1 ≤ ε and µ3 > µ2
when d2 and d3 are fixed numbers.
When the two thresholds are constants, d3 cannot be shorter than q3, α, ∞ (q3, α, ν)




2tα/2, ν) for known (unknown) variance situation.
Otherwise, the error rate will go beyond α when µ1 = µ2 = µ3 and when µ(1) ¿ µ(2) =
µ(3) respectively. Figure 3.7 shows the response surface of P (error) for the ordered
parameter space under d3 = q3, α, ∞ and d2 =
√
2zα/2. Although type I error is
controlled over every setting, P (error) is very low and even close to 0 for most of the
configurations in the graphs. It shows that the procedure with constant thresholds
is conservative. Many refinements for d2 can be made to bring up the response




THE RESTRICTED PARAMETER SPACE APPROACH
The efficacy of treatments in which the researchers are interested may not differ a lot
in clinical trials. For example, after screening out thousands of chemical compounds
and narrowing down total number of alternatives, the effective levels of those treat-
ments left are quite comparable. In reality, the range of the difference in treatment
means is bounded instead of infinite. It implies that only a restricted parameter space
is of concern. Accordingly, it is more meaningful to control the error rate and to im-
prove the efficiency of a test procedure in a certain parameter subspace rather than
the whole parameter space. In this chapter, a sharper value of d2 in the second step
of the step-down procedure is studied for a balanced design. The shorter threshold
enables the test procedure to detect more inferior treatments.
4.1 Motivation
As mentioned in section 3.3, d3 = q3, α, ∞ along with d2 =
√
2 zα/2 control P (error) ≤
α for every possible µ vector when comparing three treatments and variance is known.





≤ δ, δ > 0. Consider the following two scenarios with δbig and δsmall, δbig À
δsmall > 0. In the first case when δ is big or even goes to infinity, there is a wide
scope of the location of µ(2). The difference between µ(3) and µ(2) can also be large
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or even unbounded. Although knowing the relative locations of µ(1) and µ(3), there is
not much information about µ(2) in such a case. Therefore, it is suitable to use the
existing procedure with d2 =
√
2 zα/2 in order to satisfy Pµ(1)¿µ(2)=µ(3)(error) ≤ α.
On the other hand, suppose that the range of three treatment means is known to be










≤ δsmall. Under this type of parameter setting when three
means cluster together, it is difficult to identify the less effective treatments by using
standard thresholds in the step-down procedure mentioned before. The conservative
problem can also be seen in the response surface of Figure 3.7. For instance, the value
of Pµ1<µ2=µ3(error) is below α when the difference between µ3 and µ1 is small. This
fact motivates the adoption of a smaller d2 value when the range of treatment means
is short or bounded.
This chapter applies a constant d3 and a sharper d2(δ) value in the step-down
procedure to solve the problem of identifying inferior treatments. The value of d2(δ)
depends on the range of treatment means. The goal is to study the minimum d2(δ)






≤ δ. With the sharper critical values, the test procedure
can be more efficient to detect and select inferior treatments into the NB subset.
48
4.2 Restricted parameter space and new decision space un-









, are used for illustrating the restricted param-
eter space as before. Let σ√
n
= 1 and the upper limit of the range of treatment means
be δ, δ > 0. The parameter space of interest reduces from the whole area in Figure
3.1 to the hexagon in Figure 4.1. Every point inside the hexagon maps to a parameter
setting with µ(3) − µ(1) ≤ δ. For example, the three bold solid lines represents for
the configurations with two best treatments and 0 < µ(3) − µ(1) = µ(2) − µ(1) ≤ δ.
Similarly, the three rhombuses in light gray stand for the parameter settings having
only one best treatment and 0 ≤ µ(2) − µ(1) < µ(3) − µ(1) ≤ δ. The d2(δ) values
proposed in this chapter control familywise error rates over the restricted parameter
space inside the hexagon.
µ1 = µ2 = µ3 is a common setting having a matching point which lies within
the aforementioned restricted parameter space no matter what the positive value of
δ is. Therefore, Pµ1=µ2=µ3(error) must be less than or equal to α. This probability
constraint suggests that d3 cannot be smaller than q3, α, ν . Otherwise, the probability
of making an incorrect decision is beyond the tolerance if the true setting has three
equal means. In a balanced design, the studentized range q statistics guarantees
that the P (error) associated with the point µ1 = µ2 = µ3 = µ
∗ in the restricted
parameter space is exactly α. As a result, the threshold in the first step of the
step-down procedure cannot be improved under any restricted parameter space.
As for the rest of the restricted parameter space other than the origin point,
however, the corresponding P (error) is below α when d2 is zα/2 (see Figure 3.7).
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Figure 4.1: The restricted parameter where µ(3) − µ(1) ≤ δ.
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The improvement of power can be made for the area with |B| = 1 or 2. In those
parameter settings, d2 is one of the variables that determines Pµ1≤µ2<µ3(error) and
Pµ1<µ2=µ3(error). When d2 gets shorter, the chance of selecting any inferior treatment
into NB becomes greater.
Under the test procedure which adopts a two-step step-down procedure with d3
and d2(δ), the new decision space with a smaller d2 value is shown in Figure 4.2.
Under the constant d2, the original decision space is divided into seven subregions by
a hexagon and three pairs of parallel solid lines. When using a smaller critical value
for d2, each pair of the parallel solid lines move closer to each other to the dashed
lines. The area of selecting two treatments into the NB subset increases and the area
of eliminating one treatment decreases. As the layout of the decision space changes,
the new test procedure with d2(δ) has a higher probability to reject treatments than
the procedure with constant d2.
The new d2(δ) function needs to satisfy P (error) ≤ α within the complete re-
stricted parameter space in a similar way as how the standard d2 does. The proba-
bility of getting a point inside region (iii), (iv) , and (v) bounded by the dashed lines
in Figure 4.2 should be less than or equal to α when both µ1 and µ2 are less than
µ3. The total area from (iii) to (v) constructed by the dashed lines is larger than
that constructed by the solid lines. Since the area increases, it is easier to get a point
inside these specific regions. Thus, Pµ1≤ µ2<µ3(error) increases and so does the power
of the test procedure. Same idea is extended to the setting of µ1 < µ2 = µ3. The
total area from (iii) to (vii) bounded by the dashed lines is greater than that bounded
by the solid lines. Given the same familywise error rate, the new threshold of d2(δ)
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Figure 4.2: The new decision space by using d2(δ).
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leads to a smaller subset of possibly the best treatments which is useful for further
study.
4.3 Construction of d2(δ, α, ν)
Suppose that the prior information about the upper limit of the range in treatment
means is given. The value of d2 can be changed to a smaller constant, d2(δ), which
depends on the size of the restricted parameter subspace. Let d2(δ, α, ν) be the






≤ δ and the degree of freedom equals to ν. The value of
d2(δ, α, ν) is bounded from above by the standard value:
√
2zα/2 when variance is
known and by
√
2tα/2, ν when variance is unknown. How far away three treatment
means spread out determines the decrement in d2.
Based on Figure 3.7, the level of P (error) is higher on the boundary of the
restricted parameter space where µ(1) ≤ µ(2) = µ(3) when using constant thresh-
olds. Therefore, d2(δ, α, ν) can be calculated by tracing back the inequality of





≤ δ. Since Pµ(1)=µ(2)=µ(3)(error) = α can
be reached by setting d3 = q3, α, ν and is irrelevant to d2, only Pµ(1)<µ(2)=µ(3)(error)
needs to be confirmed.
The idea can also be seen in the properties of P (error). The conclusion of the




, δ ≥ 0 results in controlling the P (error) for all of the configurations with
µ(2) − µ(1) ≤ δ S√n . Therefore, in order to guarantee the error rate at each point of
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the restricted parameter space, d2(δ, α, ν) must satisfy Pµ(1)≤µ(2)=µ(3)(error) ≤ α.
Using q statistics as the threshold in the first step of the test procedure insures that
Pµ1=µ2=µ3(error) is exactly α in a balanced design. Under this consideration, the same
d3 value is used with d2(δ, α, ν) to construct the probability of selecting any best
treatment into NB when the underlying parameter setting has two best treatments.
The following two subsections show how d2(δ, α, ν) is constructed for both known
and unknown variance scenarios if extra information about the range of treatment
mean is well-known.
4.3.1 Known variance
Suppose that independent sample Xij from treatment i follows N(µi, σ
2), 1 ≤ i ≤





≤ δ is provided. The P (error) of the most critical case which decides the
value for the threshold in the second step of the step-down procedure is as follows.
Take the ordered means of µ1 = µ(1), µ2 = µ(2), µ3 = µ(3) to simply notation.
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Pµ1<µ2=µ3(error)
= P (X̄2, X̄3 < X̄1,























































φ(y2 − µ∗2)Φ(y2 − d3 − µ∗1)
× [Φ(y2 − d2 − µ∗3)− Φ(y2 − d3 − µ∗3)] dy2
≤ α (4.1)
[ d3 = q3, α, ∞, d2 = d2(δ, α, ∞) ]
Given an error rate of α and a range of the treatment means which equals to
δ σ√
n
, the modified threshold, d2(δ, α, ∞), must satisfy the inequality above for all of




≤ δ. The difficulty of obtaining the minimum d2
value for the restricted parameter space is that there is no closed form for d2(δ, α, ∞).
Therefore, the probability constraint should be checked at each τ ≤ δ where µ2 =
µ3 = µ1 + τ
σ√
n
. It is a mass search but the search time is not overwhelming due to
the advantage of formulating P (error) with one dimensional integration. A numerical
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search using bisection algorithm is executed to explore the best value of the threshold
in the second step of the test procedure.
During the search, it is found that Pµ1<µ2=µ3(error) has a bigger error rate near one




nomenon suggests first finding the smallest d2 value such that inequality (4.1) holds at
the parameter setting of µ2 = µ3 = µ1 + δ
σ√
n
. After that, plug in the solution to con-
firm that every Pµ1<µ2=µ3(error) is at or below α for all µ2 = µ3 = µ1 + τ
σ√
n
, τ ≤ δ.
In this way, it consumes less time to calculate d2(δ, α, ∞). Figure 4.3 presents the
results of d2(δ, α, ∞) at α equals to 5% and 1%.
Figure 4.3: d2(δ, α, ∞) values.
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4.3.2 Unknown variance
This subsection studies the d2(δ, α, ν) function when the maximum ratio of the
difference in treatment mean to σ√
n
has a upper limit of δ but the common population
variance is unknown. The goal is to separate the best treatments with the largest
mean from the inferior treatments with smaller means while controlling type I error.
Suppose that in a balanced design, independent observation Xij follows a N(µi, σ
2)
distribution, 1 ≤ i ≤ 3, 1 ≤ j ≤ n. µi and σ2 are both unknown. Then, sample mean,
X̄i, follows N(µi, σ




, ν = 3n − 3.
These two sample statistics are point estimates for µi and σ
2 respectively. Define a
random variable U as S
σ














), 0 < u < ∞.
The three properties of P (error) hold for the unknown variance case as well. Let
µ1 = µ(1), µ2 = µ(2), µ3 = µ(3). First, Pµ1≤µ2<µ3(error) also decreases as the largest
treatment mean increases when variance is unknown. The proof here is similar to the




= P (treatment 3 is selected into NB)








































































































































Second, the error rate for µ1 ≤ µ2 = µ3 is bigger than the limiting error rate
for µ1 ≤ µ2 < µ3 as the difference between µ3 and µ2 goes to zero when variance
is unknown. Based on the definition of error in this research, concluding NB =
{T1}, {T2}, {T3}, {T1, T2}, {T1, T3}, or {T2, T3} results in a wrong decision if three
treatment means are all equal. Similarly, five decisions of {T2}, {T3}, {T1, T2}, {T1, T3},
and {T2, T3} are all error decisions when the setting is µ1 < µ2 = µ3. However,
only three decisions: NB = {T3}, {T1, T3}, and {T2, T3} are incorrect decisions
when the configurations is µ1 ≤ µ2 < µ3. The larger the size of the most effec-
tive treatments is, the more error decisions a parameter setting includes. Since the
probability of concluding each decision is nonnegative, Pµ1≤µ2=µ3(error) dominates
limδ→0 Pµ1≤µ2<µ3(error) when variance is unknown as well. Last, property III of
Pµ1<µ2=µ3(error) ≤ α for unknown variance case can also be confirmed by doing
numerical calculation.
In conclusion, the most critical issue for finding the smallest d2 value for the





≤ δ. In this way,
the error rate of the entire restricted parameter space can be controlled. Since q3, α, ν
statistics makes type I error be exactly α when three treatment means are all equal,
it is enough to determine the value of d2(δ, α, ν) by examining Pµ(1)<µ(2)=µ(3)(error)
in the restricted parameter space.
Suppose that independent sample Xij from treatment i follows N(µi, σ
2), 1 ≤






is given to be less than or equal to δ. Take ordered means
for simplicity. The formulation of the P (error) at the most critical setting with two
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best treatments is as follows.
Pµ1<µ2=µ3(error)
= P (X̄2, X̄3 < X̄1,






















= P (X̄2, X̄3 < X̄1,






































φ(y2 − µ∗2)Φ(y2 − µ∗1)






φ(y2 − µ∗2)Φ(y2 − ud3 − µ∗1)
× [Φ(y2 − ud2 − µ∗3)− Φ(y2 − ud3 − µ∗3)] g(u) dy2 du
≤ α (4.2)
[ d3 = q3, α, ν , d2 = d2(δ, α, ν) ]
The way to search the minimum value for d2 is first set Pµ1<µ2=µ3(error) to α at
µ2 = µ3 = µ1 + τ
σ√
n
where τ = δ. Then, verify that the deriving solution meet the
probability requirement for all 0 < τ < δ.
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4.4 Computational results and performance
4.4.1 Computational results for d2(δ, α, ν)
The results for both known and unknown variance cases at α equals to 10%, 5% and
1% are provided in Table 4.1 to 4.3. The d2(δ, α, ν) values in the tables insures that




≤ δ. The upper
limit, δ, are tabulated from 1 to 5.
Table 4.1: d2(δ, 10%, ν) table: critical values of d2 at α = 0.1.
d2(δ) at α = 10%
ν d3 δ = 1 δ = 2 δ = 3 δ = 4 δ = 5 δ = ∞
6 3.558 1.747 2.428 2.660 2.730 2.746 2.748
9 3.316 1.676 2.303 2.514 2.577 2.591 2.592
12 3.204 1.644 2.246 2.447 2.506 2.519 2.521
15 3.140 1.625 2.212 2.409 2.466 2.478 2.479
18 3.098 1.612 2.191 2.384 2.440 2.451 2.452
24 3.047 1.598 2.165 2.353 2.407 2.418 2.420
30 3.017 1.589 2.150 2.335 2.388 2.399 2.400
45 2.978 1.578 2.129 2.311 2.363 2.374 2.375
60 2.959 1.572 2.120 2.300 2.351 2.361 2.363
120 2.930 1.565 2.105 2.283 2.333 2.343 2.344
∞ 2.902 1.556 2.091 2.266 2.315 2.325 2.326
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Table 4.2: d2(δ, 5%, ν) table: critical values of d2 at α = 0.05.
d2(δ) at α = 5%
ν d3 δ = 1 δ = 2 δ = 3 δ = 4 δ = 5 δ = ∞
6 4.339 2.257 3.068 3.349 3.437 3.457 3.460
9 3.948 2.124 2.852 3.102 3.179 3.198 3.199
12 3.773 2.067 2.756 2.991 3.063 3.080 3.081
15 3.673 2.034 2.702 2.927 2.997 3.013 3.014
18 3.609 2.014 2.666 2.887 2.954 2.970 2.971
24 3.532 1.987 2.637 2.838 2.903 2.917 2.919
30 3.486 1.972 2.598 2.809 2.873 2.887 2.888
45 3.428 1.953 2.565 2.770 2.833 2.847 2.848
60 3.399 1.945 2.547 2.753 2.815 2.827 2.829
120 3.356 1.930 2.527 2.726 2.786 2.799 2.800
∞ 3.314 1.914 2.502 2.698 2.757 2.770 2.772
Table 4.3: d2(δ, 1%, ν) table: critical values of d2 at α = 0.01.
d2(δ) at α = 1%
ν d3 δ = 1 δ = 2 δ = 3 δ = 4 δ = 5 δ = ∞
6 6.331 3.564 4.670 5.079 5.202 5.243 5.243
9 5.428 3.160 4.111 4.452 4.560 4.596 4.596
12 5.046 3.004 3.881 4.193 4.294 4.320 4.320
15 4.836 2.930 3.752 4.045 4.143 4.167 4.167
18 4.703 2.862 3.673 3.951 4.047 4.071 4.071
24 4.546 2.797 3.569 3.840 3.932 3.955 3.955
30 4.455 2.765 3.517 3.775 3.866 3.889 3.889
45 4.339 2.719 3.443 3.700 3.781 3.804 3.804
60 4.282 2.689 3.410 3.659 3.740 3.762 3.762
120 4.200 2.661 3.355 3.600 3.680 3.702 3.702
∞ 4.120 2.618 3.300 3.540 3.620 3.640 3.643
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If the difference between treatment means is small, the threshold of d2(δ, α, ν)






≤ 1 at six degree of freedom and α = 5%. The difference
between d2(δ, α, ν) and the standard d2 becomes minor as δ gets greater than 3.
The improvement of d2 is more significant when degree of freedom is larger, especially
when variance is known. When δ equals to ∞, d2(δ, α, ν) is exactly the standard
constant, tα/2, ν , which guarantees the error rate of the whole parameter space. More-
over, under same degree of freedom and δ, the ratio of d2(δ, α, ν) to the standard d2
value is lower when α is high.
4.4.2 Power of d2(δ, α, ν)
There are several ways to define the power of a test procedure depending on the
goal of a problem. In this study, the power of a test procedure is defined as the
ability to detect any less effective treatment with small µ. Two types of measurement
for power are discussed throughout the thesis: (1) the probability of identifying any
inferior treatment and (2) the expected size of inferior treatments selected into the
NB subset. Consequently, the way to formulate the power depends on the parameter
setting.
When comparing three treatments, there are seven decisions available: NB =
{φ}, {T1}, {T2}, {T3}, {T1, T2}, {T1, T3} and {T2, T3}. Denote P{φ}(µ), P{T1}(µ), · · · ,
and P{T2,T3}(µ) as the probabilities of selecting no treatment, the treatment with
µ1, · · · , and the treatments with µ2 and µ3 into NB respectively. Table 4.4 lists
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Table 4.4: Power calculation.
Power
µ setting (1) P (i ∈ NB|i /∈ B, 1 ≤ i ≤ 3) (2) E[i ∈ NB|i /∈ B, 1 ≤ i ≤ 3]
µ1 = µ2 = µ3 P{φ}(µ) 0
µ1 < µ2 = µ3 P{T1}(µ) + P{T1,T2}(µ) + P{T1,T3}(µ) P{T1}(µ) + P{T1,T2}(µ) + P{T1,T3}(µ)
µ1 ≤ µ2 < µ3
P{T1}(µ) + P{T2}(µ) + P{T1,T2}(µ)+ P{T1}(µ) + P{T2}(µ) + 2× P{T1,T2}(µ)+
+ P{T1,T3}(µ) + P{T2,T3}(µ) +P{T1,T3}(µ) + P{T2,T3}(µ)
the measurement of power for three types of configurations according to the size
of the best treatments. The test procedure which possesses higher quantity in the
measurement is said to be more efficient. Measurement (2) is computed as the
probability of identifying any inferior treatment multiplies the number of the in-
ferior treatments successfully selected into NB. For example, suppose that µ1 ≤
µ2 < µ3 with |B| = 1. Both treatment 1 and 2 are less effective than treat-
ment 3. Any decision which contains either T1, T2 or both has correct detection.
NB = {T1}, {T2}, {T1, T3} and {T2, T3} are the conclusions which correctly eliminate
one of the inferior treatments and thus the corresponding probabilities are multiplied
by one. Concluding NB = {T2, T3} precisely detect both inferior treatments, so the
associated probability is weighted by two.
The calculation of power is determined by the probability of getting each deci-
sion, P{φ}, P{T1}, · · · , and P{T2,T3}. Thus, it is necessary to study the probability of
deriving each decision first. Without loss of generality, assume that σ√
n
= 1. The
total probability of getting these seven combinations is 1. A more general case with
arbitrary sample size and known or unknown variance can be easily extended from
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these formulas below.
P{φ}(µ) = P (X̄(3) − X̄(1) ≤ d3)
= P (X̄1 < X̄2, X̄3 ≤ X̄1 + d3))
+P (X̄2 < X̄1, X̄3 ≤ X̄2 + d3))




φ(x1 − µ1) [Φ(x1 + d3 − µ2)− Φ(x1 − µ2)]




φ(x2 − µ2) [Φ(x2 + d3 − µ1)− Φ(x2 − µ1)]




φ(x3 − µ3) [Φ(x3 + d3 − µ1)− Φ(x3 − µ1)]
× [Φ(x3 + d3 − µ2)− Φ(x3 − µ2)] dx3 (4.3)
P{T1}(µ) = P (X̄1 < X̄2 − d3, X̄2 − d2 ≤ X̄3 < X̄2)








φ(x3 − µ3)Φ(x3 − d3 − µ1)[Φ(x3 − µ2)− Φ(x3 − d2 − µ2)] dx3
(4.4)
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P{T2}(µ) = P (X̄2 < X̄1 − d3, X̄1 − d2 ≤ X̄3 < X̄1)








φ(x3 − µ3)Φ(x3 − d3 − µ2)[Φ(x3 − µ1)− Φ(x3 − d2 − µ1)] dx3
(4.5)
P{T3}(µ) = P (X̄3 < X̄1 − d3, X̄1 − d2 ≤ X̄2 < X̄1)








φ(x2 − µ2)Φ(x2 − d3 − µ3)[Φ(x2 − µ1)− Φ(x2 − d2 − µ1)] dx2
(4.6)
P{T1,T2}(µ) = P (X̄1, X̄2 < X̄3 − d3)
+P (X̄1 < X̄3 − d3, X̄3 − d3 ≤ X̄2 < X̄3 − d2)








φ(x3 − µ3)Φ(x3 − d3 − µ1)




φ(x3 − µ3)Φ(x3 − d3 − µ2)
×[Φ(x3 − d2 − µ1)− Φ(x3 − d3 − µ1)] dx3 (4.7)
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P{T1,T3}(µ) = P (X̄1, X̄3 < X̄2 − d3)
+P (X̄1 < X̄2 − d3, X̄2 − d3 ≤ X̄3 < X̄2 − d2)








φ(x2 − µ2)Φ(x2 − d3 − µ1)




φ(x2 − µ2)Φ(x2 − d3 − µ3)
×[Φ(x2 − d2 − µ1)− Φ(x2 − d3 − µ1)] dx2 (4.8)
P{T2,T3}(µ) = P (X̄2, X̄3 < X̄1 − d3)
+P (X̄2 < X̄1 − d3, X̄1 − d3 ≤ X̄3 < X̄1 − d2)








φ(x1 − µ1)Φ(x1 − d3 − µ2)




φ(x1 − µ1)Φ(x1 − d3 − µ3)
×[Φ(x1 − d2 − µ2)− Φ(x1 − d3 − µ2)] dx1 (4.9)
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The power of the new procedure can be calculated by substituting d2 with the tab-
ulated d2(δ, α, ν) value into the aforementioned equations. The computational results
demonstrate that the new test procedure is more powerful than the standard proce-
dure in terms of both measurements. Figure 4.4 to 4.8 present the power improvement
by using the new methodology. The graphs demonstrate the difference of the two ap-
proaches under three types of parameter setting: (1) µ(1) = µ(2) < µ(3) : (0, 0, δ) (2)
µ(1) < µ(2) = µ(3) : (0, δ, δ) (3) µ(1) < µ(2) < µ(3) : (0,
δ
2
, δ). The graphs in the left
column illustrate the power improvement in terms of the probability of identifying
any inferior treatment while those in the right column are in terms of the expected
size of any inferior treatment selected into the NB subset.
If the range of three treatment means is known to be small, the d2(δ, α, ν) func-
tion provides sharper critical values that enable the test procedure to detect more
inferior treatments in the step-down procedure. When α and the degree of freedom





decreases. As δ gets smaller, the area of the parameter subspace whose P (error)
needs to be controlled becomes tighter. Therefore, a smaller d2 value which results
in a larger decision error rate can still guarantee P (error) ≤ α for the restricted pa-
rameter space. Then the power raises along with type I error. When δ and degree of
freedom are fixed to given numbers, greater improvement in identifying less effective
treatments can be achieved if tolerance of familywise error rate is relaxed to a larger
value. Moreover, power in both measurements increase more under high degree of
freedom when δ and α remain constants.
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Figure 4.4: Power improvement by using d2(δ = 1) at α = 1% and known variance.
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Figure 4.5: Power improvement by using d2(δ = 1) at α = 5% and known variance.
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Figure 4.6: Power improvement by using d2(δ = 1) at α = 10% and known variance.
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Figure 4.7: Power improvement by using d2(δ = 2) at α = 5% and known variance.
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Figure 4.8: Power improvement by using d2(δ = 1) at α = 5% and ν = 60.
73
4.5 Discussion and summary
The treatment with a smaller mean value is considered as less effective and should





≤ δ, δ > 0 is provided
before testing the strictly inferior treatments. With the additional information about
the range of treatment means, the test procedure can be less conservative by moni-
toring the P (error) within a restricted parameter space. The goal of this chapter is
to design an efficient test procedure which can identify more inferior treatments when
the differences among µi’s are known to be bounded. The objective can be reached
by using sharper thresholds, d2(δ, α, ν), for the restricted parameter space.





≤ δ. The crit-
ical value is smaller than standard d2,
√
2tα/2,ν . The calculation time for d2(δ, α, ∞)
is not overwhelming due to the benefit of formulating the error rate with one integral.
The new threshold is computed by finding the minimum d2 value such that the error
rate of µ(1) < µ(2) = µ(3) is not greater than α when µ(3) − µ(1) ≤ δ σ√n . If σ√n is one,
the solution maintains familywise error rate inside the restricted parameter space of
the hexagon in Figure 4.1.
The new d2(δ, α, ν) value, in fact, can guarantee a subspace larger then the
hexagon. Property I and II of P (error) states that if Pµ(1)≤µ(2)=µ(3)(error) is at or
below α for some τ = µ(3) − µ(1), then Pµ(1)≤µ(2)<µ(3)(error) is also below α whenever
µ(2)− µ(1) < τ . Therefore, the tabulated d2(δ, α, ν) values actually control the error





≤ δ as shown in Figure 4.9.
The advantage of applying d2(δ, α, ν) to the step-down procedure is that not
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only is the error rate controlled over the interested parameter subspace, but also does
the power of the test procedure increase. There is a higher chance to exclude the
inferior treatments among three. Meanwhile, the expected size of the less effective
treatments being rejected is bigger than that by applying standard d2.








THE STEP-DOWN PROCEDURE WITH FEEDBACK
In a balance design with three populations, using the studentized range statistics,
q3, α, ν , as the threshold in step 1 of the step-down procedure makes P (error) exactly
α if the true parameter has three equal means. It implies that d3 cannot be smaller
than the q statistics; otherwise, the error rate is out of control for the configuration
of µ1 = µ2 = µ3. As for the rest of the parameter settings, the probability of
selecting any treatment with the largest mean into NB relies on the two thresholds
in both steps. Such a probability is a function of d2 and d3. When using standard
d2 = tα/2, ν and d3 = q3, α, ν , however, most configurations have error rates less than
α. The numerical calculations shows that the constant d2 value is not powerful in
eliminating less effective treatments when there are at least one inferior treatments.
This chapter proposes a new step-down procedure with feedback to adjust the value
of d2 for every individual experiment. Under this methodology, d2 is no longer a
constant but a function depending on range of sample means.
Similar to the previous chapter, the methodology presented here focuses on k = 3
case. The proposing d2(X̄(3) − X̄(1)) function along with q statistics control type I
error at or below α no matter what the true parameter setting is. The objective of
this approach emphasizes monitoring error rates and improving power for the whole
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parameter space instead of focusing on a restricted parameter subspace. Prior in-
formation about range of treatment means is not needed and nor does it change the
value of d2. Only relative location of sample means is used to modify d2.
5.1 Motivation
As a motivation for the new procedure, consider the two data configurations shown
in Figure 5.1. In either case treatment 1 will be put into NB, and if d2 is a constant
then the same decision will be made for treatment 2 in either case as well. The idea of
the new procedure is that different decisions can be made possible for treatment 2 for
the two cases by allowing the critical point d2 to depend upon the value of X̄(3)−X̄(1).
Thus, the decision at the second step incorporates feedback from the first step. This
chapter studies the formulation and the performance of applying the d2(X̄(3) − X̄(1))
function in the step-down procedure.
Figure 5.1: Motivation of using d2(X̄(3) − X̄(1)).
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5.2 Construction of the d2(X̄(3) − X̄(1)) function
When testing homogeneity of two population means, zα/2 statistics or tα/2, ν statistics
are used to control type I error at α level. Same concept applies to the step-down




2tα/2, ν leads to an asymptotic error rate of α
when the configuration is µ(1) ¿ µ(2) = µ(3). Figure 3.7 demonstrates the conservative
problem of applying constant d2. P (error) promptly drops to zero as µ(3)− µ(2) gets
large. For the area with low error rate, a smaller d2 can also meet the probability





2tα/2, ν for known and unknown variance respectively.
As the gap among the efficacy levels shrinks, the standard procedure becomes
less powerful. It is difficult to discriminate treatments when sample means cluster
together. In order to improve efficiency of the test procedure, d2 is formulated as
a function whose value changes with observations. The d2(X̄(3) − X̄(1)) function
converges to the standard d2 value as the range of sample means goes to infinity but





is not much wider
than d3. Hence, a concave function is proposed:











, for known variance











, for unknown variance
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5.2.1 New decision space under d2(X̄(3) − X̄(1))
The layout of decision space turns into Figure 5.2 when applying the exponential
functions proposed above. Since the cutting point in the first step of the test procedure
is still q statistics, the size of the hexagon remains the same. However, the decision
rule in step 2 is not a fixed number for every data set. Its value depends on the
difference between the maximum and the minimum sample means. Accordingly, the
borders between concluding one and two inferior treatments change from straight
lines to curves.
The step-down procedure with feedback is designed to control familywise error rate
for every possible parameter setting. The solutions for a and b in the d2(X̄(3) − X̄(1))
function are subject to P (error) ≤ α. When µ1 = µ2 = µ3, the probability of
observing a point outside the hexagon of the decision space is exact α by applying
d3 = q3, α, ν in a balance design. If µ1 < µ2 = µ3, the chance of matching sample
means to a point inside region (iii) to (vii) bounded by the dashed curves must less
than or equal to α. As it can be seen in Figure 5.2, the total area from (iii) to (vii)
bounded by the dashed curves is bigger than that bounded by the solid lines. Hence,
Pµ1<µ2=µ3(error) increases and so does the power of the test procedure applying the
d2(X̄(3) − X̄(1)) function. Similarly, the probability of getting a point inside region
(iii) to (v) bounded by the dashed curves is required to be at or below α when
µ1 ≤ µ2 < µ3. The total area is greater than that bounded by the solid lines by two
shaded areas.
P (error) is a function of d2 and d3 if one or more less effective treatments exist.
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Figure 5.2: The new decision space by using d2(X̄(3) − X̄(1)).
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When applying the standard procedure with a constant d2 value of
√
2zα/2, P (error)
can be constructed by one integral under known variance case. As for the restricted
parameter space approach proposed in chapter 4, it is also sufficient to describe the
error rate with one integral when variance is given. With regard to the step-down
procedure with feedback, however, the formulation of the d2(X̄(3) − X̄(1)) function is
more complicated due to the function depends on the relative location of the largest
and the smallest sample means. The expression for P (error) requires double integra-
tion to characterize X̄(1) and X̄(3) when variance is known and raises the complexity
of the problem and calculation.
It is necessary to reconfirm the three properties after constructing new equations
for P (error). The second property comments that Pµ1≤µ2=µ3(error) is bigger than
limδ→0 Pµ1≤µ2<µ3(error) where δ = µ3 − µ2. The statement is also true when d2 is a
function of X̄(3)− X̄(1). No matter d2 is a fixed number or a function, the probability
of concluding each decision is nonnegative. Based on the definition of error, more
types of conclusions are considered to be error decisions when µ1 ≤ µ2 = µ3 than
when µ1 ≤ µ2 < µ3. The error rate of the configuration with two best treatments is
higher than than the limiting error rate of the setting with one best treatment.
The proof of property I becomes complicated due to having two integrals involved.
The property can be checked by numerical calculation. When fixing µ1, µ2, a and b,
the numerical result shows that Pµ1≤µ2<µ3(error) decreases as µ3 increases. The plot
of the first derivative of Pµ1≤µ2<µ3(error) with respect to µ3 is negative and converges
to zero as µ3 increases. The phenomenon for property I and the proof of property II
together suggest that the configuration with two best treatments is potentially the
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most critical scenario in determining d2.
Therefore, the construction of the d2(X̄(3) − X̄(1)) function can be started with
searching for the solutions of a and b which satisfy Pµ1<µ2=µ3(error) ≤ α. Then, the
P (error) under such solutions needs to be examined for the whole parameter space.
The next two sections formulate Pµ(1)<µ(2)=µ(3)(error) under the step-down procedure
with feedback which adjusts the value of d2 with observations.
5.2.2 Known variance
Let Xij be the j
th independent observation from treatment i, 1 ≤ i ≤ 3, 1 ≤ j ≤ n.
Suppose that Xij ∼ N(µi, σ2), σ2 is given. Take ordered means, µ(i) = µi, 1 ≤ i ≤ 3,
to simplify notation. The formulation of type I error for the parameter setting of
µ1 < µ2 = µ3 is displayed as follows. Solutions for a and b must first satisfy inequality
(5.1) for all µ1 < µ2 = µ3.
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Pµ1<µ2=µ3(error) = P (T2, T3 ∈ NB)
= P (X̄1 < X̄3 − d3 σ√
n
, X̄1 < X̄2 < X̄3 − d2 σ√
n
)
+P (X̄1 < X̄2 − d3 σ√
n
, X̄1 < X̄3 < X̄2 − d2 σ√
n
)
+P (X̄2 < X̄1 < X̄3 and X̄2 < X̄3 − d3 σ√
n
)
+P (X̄2 < X̄3 < X̄1 and X̄2 < X̄1 − d3 σ√
n
)
+P (X̄3 < X̄1 < X̄2 and X̄3 < X̄2 − d3 σ√
n
)
+P (X̄3 < X̄2 < X̄1 and X̄3 < X̄1 − d3 σ√
n
)
= 2P (X̄1 < X̄3 − d3 σ√
n





P (X̄2 < X̄1, X̄3)− P (X̄2 < X̄1 ≤ X̄2 + d3 σ√
n




















φ(y2 − µ∗2) {[1− Φ(y2 − µ∗1)] [1− Φ(y2 − µ∗3)]
− [Φ(y2 + d3 − µ∗1)− Φ(y2 − µ∗1)] [Φ(y2 + d3 − µ∗3)− Φ(y2 − µ∗3)]} dy2
≤ α (5.1)
5.2.3 Unknown variance
The formulation of the error rate for unknown variance is an extension of inequality
(5.1). Sample standard deviation, S, is used to substitute unknown parameter σ.
One more integral is added to the equation to take sample standard deviation into
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consideration. Define a random variable U as S
σ














), 0 < u < ∞, ν = 3n− 3
Following is the formula of Pµ1<µ2=µ3(error) based on the step-down procedure
with feedback when variance is not given. The goal is to solve a and b such that the
inequality below is guaranteed for all of the configurations with two best treatments.
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Pµ1<µ2=µ3(error)
= P (T2, T3, or both ∈ NB)
= P (X̄1 < X̄3 − d3 S√
n
, X̄1 < X̄2 < X̄3 − d2 S√
n
)
+P (X̄1 < X̄2 − d3 S√
n
, X̄1 < X̄3 < X̄2 − d2 S√
n
)
+P (X̄2 < X̄1 < X̄3 and X̄2 < X̄3 − d3 S√
n
)
+P (X̄2 < X̄3 < X̄1 and X̄2 < X̄1 − d3 S√
n
)
+P (X̄3 < X̄1 < X̄2 and X̄3 < X̄2 − d3 S√
n
)
+P (X̄3 < X̄2 < X̄1 and X̄3 < X̄1 − d3 S√
n
)
= 2P (X̄1 < X̄3 − d3 S√
n





P (X̄2 < X̄1, X̄3)− P (X̄2 < X̄1 ≤ X̄2 + d3 S√
n

































































































g(u)φ(y1 − µ∗1)φ(y3 − µ∗3)
×
[
Φ(y3 − u ·
√








g(u)φ(y2 − µ∗2) {[1− Φ(y2 − µ∗1)][1− Φ(y2 − µ∗3)]
− [Φ(y2 + ud3 − µ∗1)− Φ(y2 − µ∗1)]× [Φ(y2 + ud3 − µ∗3)− Φ(y2 − µ∗3)]} dy2 du
≤ α (5.2)
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5.2.4 Optimal solution for the d2(X̄(3) − X̄(1)) function
Inequality (5.1) and (5.2) have multiple paired solutions for (a, b). The goal of the
step-down procedure with feedback is to propose a new methodology which increases
the power of the test procedure while maintaining familywise error rate at the same
time. Therefore, it is preferable to choose the d2(X̄(3)− X̄(1)) function which provides
the greatest improvement in power among all of the feasible solutions.
The decision spaces under the step-down procedures with constant d2, d2(δ), and
d2(X̄(3) − X̄(1)) are all symmetric. Treatment index does not influence decision. Fig-
ure 5.3 shows the difference between the decision spaces under standard d2 and the
d2(X̄(3) − X̄(1)) function. Suppose that X̄1 ≤ X̄2 ≤ X̄3, the new d2(X̄(3) − X̄(1))
function creates a larger area for concluding NB = {T1, T2} and then is more capa-
ble of eliminating one more treatment when comparing three treatments. If sample
means match to a point locating in the shaded area, only the treatment with the
smallest sample mean is eliminated under the standard method. On the other hand,
the treatments with the smallest two sample means are rejected under the step-down
procedure with feedback if observing such a point. The size of the shaded area can
then be measurement of power improvement. It represents the performance level of
the d2(X̄(3) − X̄(1)) function. Thus, the larger the area is, the more powerful the





2tα/2ν · ea−bx dx
86
Figure 5.3: The improvement of the step-down procedure with feedback over the
standard step-down procedure.
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5.3 Computational results and performance
5.3.1 Computational results for the d2(X̄(3) − X̄(1)) function











when variance is known
and is
√









when variance is unknown. The results of the
optimal (a, b) at certain α levels and degree of freedoms are tabulated below. The
proposing (a, b) values create the largest shaded area among all feasible solutions.
In addition, using d3 = q3, α, ν and d2(X̄(3) − X̄(1)) with the optimal (a, b) controls
type I error rate at or below α for the whole parameter space by numerical calculation.
Table 5.1: Optimal (a, b) for the step-down procedure with feedback approach.
α ν a b
1% ∞ 16.4 4.8
5% ∞ 17.1 5.9
10% ∞ 20.5 7.8
5% 30 26.4 8.0
The way to apply the step-down procedure with feedback is to use q statistics for
d3 and calculate the value of d2 by plugging the optimal (a, b) into the d2(X̄(3)−X̄(1))
function. For example, X̄1 = 0, X̄2 = 0.3, X̄3 = 1.7, and the ratio of the variance to





















= 3.4 > d3 = q3, 0.05, ∞ = 3.314.











= 2.8 > d2 = 2.628.
Treatment 2 is selected into NB and stop.
The conclusion is NB = {T1, T3}.
5.3.2 Power of the d2(X̄(3) − X̄(1)) function
The definition of the power for a test procedure is the ability of identifying any inferior
treatment. The probability of eliminating any inferior treatment and the expected size
of the inferior treatments selected into NB are the measurement for power adopted
in this study. The test procedure having larger quantity for the measurement is more
efficient. Refer to Table 4.4, the calculation of power is determined by the total
number of the best treatments. In order to quantify the power of a test procedure, it
is necessary to compute the probabilities of getting seven different decisions. Without
loss of generality, assume that n = 1 and σ2 = 1. A more general case with arbitrary
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n, σ2, or even unknown σ2 can be easily extended from the equation below. Let d2(y)





P{φ}(µ) = P (X(3) −X(1) ≤ d3)
= P (X1 = min {X1, X2, X3}, X2, X3 ∈ (X1, X1 + d3))
+P (X2 = min {X1, X2, X3}, X1, X3 ∈ (X2, X2 + d3))




φ(x1 − µ1) [Φ(x1 + d3 − µ2)− Φ(x1 − µ2)]




φ(x2 − µ2) [Φ(x2 + d3 − µ1)− Φ(x2 − µ1)]




φ(x3 − µ3) [Φ(x3 + d3 − µ1)− Φ(x3 − µ1)]
× [Φ(x3 + d3 − µ2)− Φ(x3 − µ2)] dx3 (5.3)
P{1}(µ) = P (X1 < X2 − d3, X2 − d2 ≤ X3 < X2)






φ(x1 − µ1)φ(x2 − µ2)






φ(x1 − µ1)φ(x3 − µ3)
×[Φ(x3 − µ2)− Φ(x3 − d2(x3 − x1)− µ2)] dx1 dx3 (5.4)
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P{2}(µ) = P (X2 < X1 − d3, X1 − d2 ≤ X3 < X1)






φ(x2 − µ2)φ(x1 − µ1)






φ(x2 − µ2)φ(x3 − µ3)
×[Φ(x3 − µ1)− Φ(x3 − d2(x3 − x2)− µ1)] dx2 dx3 (5.5)
P{3}(µ) = P (X3 < X1 − d3, X1 − d2 ≤ X2 < X1)






φ(x3 − µ3)φ(x1 − µ1)






φ(x3 − µ3)φ(x2 − µ2)
×[Φ(x2 − µ1)− Φ(x2 − d2(x2 − x3)− µ1)] dx3 dx2 (5.6)
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P{1,2}(µ) = P (X1, X2 < X3 − d3)
+P (X1 < X3 − d3, X3 − d3 ≤ X2 < X3 − d2)










φ(x1 − µ1)φ(x3 − µ3)






φ(x2 − µ2)φ(x3 − µ3)
×[Φ(x3 − d2(x3 − x2)− µ1)− Φ(x3 − d3 − µ1)] dx2 dx3 (5.7)
P{1,3}(µ) = P (X1, X3 < X2 − d3)
+P (X1 < X2 − d3, X2 − d3 ≤ X3 < X2 − d2)










φ(x1 − µ1)φ(x2 − µ2)






φ(x3 − µ3)φ(x2 − µ2)
×[Φ(x2 − d2(x2 − x3)− µ1)− Φ(x2 − d3 − µ1)] dx3 dx2 (5.8)
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P{2,3}(µ) = P (X2, X3 < X1 − d3)
+P (X2 < X1 − d3, X1 − d3 ≤ X3 < X1 − d2)










φ(x2 − µ2)φ(x1 − µ1)






φ(x3 − µ3)φ(x1 − µ1)
×[Φ(x1 − d2(x1 − x3)− µ2)− Φ(x1 − d3 − µ2)] dx3 dx1 (5.9)
The power improvement of known variance cases at α = 1%, 5%, 10% are illus-
trated in Figure 5.4 to 5.6. The subplots in the left column illustrate the increase in the
probability of eliminating any inferior treatment by applying the d2(X̄(3)−X̄(1)) func-
tion with feedback. The graphs in the right column reveal the gain in the expected size
of the less efficient treatments being selected into NB. In each setting, three types of
the parameter configurations are studied individually: (1) µ(1) = µ(2) < µ(3) : (0, 0, δ)
with one best treatment, (2) µ(1) < µ(2) = µ(3)) : (0, δ, δ) with two best treatments,





) with one best treatment.
The levels of the improvement are different from setting to setting. In terms
of the first measurement of power, P (i ∈ NB|i /∈ B, 1 ≤ i ≤ 3), the parameter
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setting with two best treatment benefits more from the d2(X̄(3)− X̄(1)) function than
the setting with only one best treatment. For instance, in Figure 5.6 with α =




) is 7 × 10−4 while 2 × 10−4 for (0, 1
2
, 1). Based
on the properties of P (error), the configuration of µ(1) < µ(2) = µ(3) significantly
influences the value for the threshold in step 2 of the test procedure. Therefore, the
d2(X̄(3) − X̄(1)) function focuses on modifying the probability of the setting with two
best treatments. The graphs show that at a fixed degree of freedom, the magnitude
of the improvement is larger if a higher type I error rate is allowed.
When comparing to the step-down procedure with constant d2, the step-down pro-
cedure with feedback has minor improvement in power than the restricted parameter
space approach if δ is small. It is because that the procedure proposed in this chapter
controls P (error) ≤ α for the whole parameter, while the procedure studied in chap-
ter 4 maintains the probability restriction for only a narrower parameter subspace.
Since there are more constraints, less improvement can be made.
5.4 Summary
The step-down procedure is one approach to differentiate the most effective treatments
from the inferior ones. It is preferable to have a small number of potentially the best
treatments so that it is easier to target the best one. In other words, the procedure
is more efficient if it can detect and eliminate more inferior treatments. However, the
standard step-down procedure with constant thresholds is conservative. Although the
standard procedure controls familywise error rate for every possible setting, P (error)
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is far below α for most of the settings. It is difficult for the test procedure with
standard d2 to reject the treatments.
This chapter proposes a new methodology for comparing three treatment means.
The data conveys information about true parameter configuration and thus can be
used to alleviate the problem of conservativeness. The step-down procedure with
feedback uses the same threshold as the standard method in step one. But, the
approach utilizes the range of sample means to sharper the threshold in step two. d2
is no longer a constant but a concave function converging to the standard d2. The
value gets smaller as sample range gets shorter.
The d2(X̄(3)−X̄(1)) function controls P (error) ≤ α for the whole parameter space
as well as possesses higher power than the standard procedure. Moreover, it is easy
to apply the new approach. After solving the optimal solution for (a, b) in the
d2(X̄(3) − X̄(1)) function, it is simple to determine the value of d2.
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at α = 1%.
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at α = 5%.
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The restricted parameter space approach and the step-down procedure with feedback
are designed for comparing three treatment means in a balanced design. The method-
ologies are constructed under several assumptions including independency, normality,
and equal variances. The procedures assume that independent samples follow a Nor-
mal distribution with a mean µi, 1 ≤ i ≤ 3 and a common variance σ2. The following
chapter simulates different parameter settings to test the performance of the three
step-down procedures when the assumptions do not hold.
The simulation studies the known variance case at α = 5% for 100,000 times.
In each run, ten observations are generated from each group under a certain distri-
bution. Some of the assumptions are violated when generating data. For example,
one population follows a t distribution, observation are dependent, and the vari-
ances of three groups are not all the same. The ideal variance is set to 10 and
σ√
n






= 1 after standardization. The first methodology uses standard
d2 =
√
2zα/2 = 2.772. The second methodology applies the restricted parameter space
approach with d2 = d2(δ = 1) = 1.914. The last one adopts the step-down procedure






≤ 2.772. The values
of d3 are all q3, 0.05, ∞ = 3.314 for the three methods. The difference between sample
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means are then compared with the critical points to determine wether rejecting any
treatment based on the rules of each test procedure.
6.1 Simulation settings
Since each group is allotted a distribution with a certain mean value, it is well-
known that which treatments are the best ones. The best treatment refers to the
population with the largest µ among three treatments. Two numbers are recorded
during simulation: the frequency of rejecting any best treatment and eliminating any
inferior treatment. The ratios of the frequencies to the total number of runs are type
I error and power of test procedures. 95% confidence intervals are also provided.
Following are the eight settings with different types of relaxation. (1 ≤ j ≤ 10)
• Case I: Dependency within the group
Suppose that the assumption of independency is violated. The observations
from same treatment are dependent. The covariance matrix of ten samples












X1j ∼ MV N(0, Σ), X2j ∼ MV N(0, Σ), X3j ∼ MV N(1, Σ), X1j, X2j, and X3j
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are independent between groups.
Setting 2:
X1j ∼ MV N(0, Σ), X2j ∼ MV N(1, Σ), X3j ∼ MV N(1, Σ), X1j, X2j, and X3j
are independent between groups.
• Case II: Unequal variances
Suppose that one or more populations have variances other than 10. The as-
sumption of equal variance does not hold.
Setting 3:
X1j ∼ N(0, 10), X2j ∼ N(0, 10), X3j ∼ N(1, var), Xij are all independent.
Setting 4:
X1j ∼ N(0, 10), X2j ∼ N(1, var), X3j ∼ N(1, var), Xij are all independent.
• Case III: Uniform distribution
The normality assumption is relaxed. Suppose that one population follows an




X1j ∼ N(0, 10), X2j ∼ N(0, 10), X3j ∼ Unif(0, 2), Xij are all independent.
Setting 6:
X1j ∼ N(0, 10), X2j ∼ N(1, 10), X3j ∼ Unif(0, 2), Xij are all independent.
• Case IV: t distribution
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Suppose that one or two populations follow a
√
10tdf distribution with mean
equals to zero. For those groups do not meet the normality assumption, the
corresponding variances are not 10, either.
Setting 7:
X1j ∼ N(−1, 10), X2j ∼ N(−1, 10), X3j ∼
√
10 · tdf , Xij are all independent.
Setting 8:
X1j ∼ N(−1, 10), X2j ∼
√
10 · tdf , X3j ∼
√
10 · tdf , Xij are all independent.
6.2 Simulation results
The simulation results show that the restricted parameter space approach and the
step-down procedure with feedback have higher frequencies in both type I error and
power than the standard d2 method. The difference is due to applying a shorter
threshold in the second step of the step-down procedure. In general, the restricted
parameter space approach has greater power improvement than the step-down pro-
cedure with feedback in these eight settings. The reason is that the given range of
treatment means is relative tight so that d2(δ) is often shorter than d2(X̄(3) − X̄(1)).
If δ is greater than three, the restricted parameter space approach may not outper-
forms the step-down procedure with feedback. Although the step-down procedure
with feedback has less improvement in the simulation, the methodology can satisfy
P (error) ≤ α under more settings where the assumptions do not hold. The procedure
accommodates to stronger violation of the assumptions.
102
The constraint of P (error) ≤ α holds for the settings with mild relaxation of the
assumptions. Especially, the configuration with uniquely the best treatment allows
a stronger magnitude of violation than the setting with two best treatments. The
phenomenon can be referred to the properties of P (error) that the error rate at
µ(1) ≤ µ(2) < µ(3) is lower than that at µ(1) < µ(2) = µ(3).
When the best treatment is unique, both new methods work if the correlation
between the samples within the group is less than or equal to one as shown in Table
6.1. If the most effective treatment has an unequal variance, follows an uniform dis-
tribution or t distribution in case 3, 5, and 7, the new approaches perform properly as
well. Familywise error rate are all smaller than 5% in Table 6.5, 6.9, and 6.13. On the
other hand, when the size of the best treatments is two, type I error rate is less than
8% if the existing correlation is less than 0.25 and 0.5 for d2(δ) and d2(X̄(3) − X̄(1))
procedures respectively. In case 4 when the variances of the best treatments are no
longer ten, the d2(δ) procedure can accept a variance less than 12 and a variance
smaller than 14 for the d2(X̄(3) − X̄(1)) procedure while having P (error) around 7%.
Case 8 relaxes the normality assumption and let the best treatments follow a
√
10 · tdf
distribution. When df is infinity,
√
10tdf is a N(0, 10) distribution. The d2(δ) pro-
cedure leads to an error rate around 6% when the degree of freedom shrinks to 18.
And the d2(X̄(3)− X̄(1)) procedure even gives an error rate smaller than 6% when the
degree of freedom diminishes to 9.
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6.3 Summary
In conclusion, the restricted parameter space approach and the step-down procedure
with feedback guarantees the error rate when the violation of the assumptions is
moderate. Especially, a more serious violation is acceptable when µ(1) ≤ µ(2) < µ(3)
which contains more parameter settings than µ(1) < µ(2) = µ(3). The new approaches
function appropriately for most of the configurations in the parameter space even
though the assumption do not exist. Moreover, the two procedures are more effective
in identifying and eliminating inferior treatments than the procedure with standard
d2.
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Table 6.1: Type I error with a 95% confidence interval for setting 1: X1j ∼
MV N(0, Σ), X2j ∼ MV N(0, Σ), X3j ∼ MV N(1, Σ).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
ρ L center U L center U L center U
0 0.00270 0.00304 0.00338 0.00520 0.00567 0.00614 0.00276 0.00311 0.00346
0.25 0.00654 0.00706 0.00758 0.01132 0.01199 0.01266 0.00669 0.00721 0.00773
0.5 0.01289 0.01361 0.01433 0.02040 0.02129 0.02218 0.01311 0.01383 0.01455
1 0.02913 0.03019 0.03125 0.04200 0.04326 0.04452 0.02958 0.03065 0.03172
2 0.07164 0.07325 0.07486 0.09442 0.09625 0.09808 0.07228 0.07390 0.07552
Table 6.2: Power with a 95% confidence interval for setting 1: X1j ∼ MV N(0, Σ),
X2j ∼ MV N(0, Σ), X3j ∼ MV N(1, Σ).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
ρ L center U L center U L center U
0 0.10002 0.10189 0.10376 0.10076 0.10264 0.10452 0.10007 0.10195 0.10383
0.25 0.14060 0.14277 0.14494 0.14190 0.14408 0.14626 0.14063 0.14280 0.14497
0.5 0.17660 0.17898 0.18136 0.17930 0.18169 0.18408 0.17669 0.17907 0.18145
1 0.24466 0.24733 0.25000 0.24990 0.25259 0.25528 0.24489 0.24757 0.25025
2 0.35051 0.35347 0.35643 0.36147 0.36445 0.36743 0.35082 0.35378 0.35674
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Table 6.3: Type I error with a 95% confidence interval for setting 2: X1j ∼
MV N(0, Σ), X2j ∼ MV N(1, Σ), X3j ∼ MV N(1, Σ).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
ρ L center U L center U L center U
0 0.02714 0.02817 0.02920 0.04857 0.04992 0.05127 0.02793 0.02897 0.03001
0.25 0.04914 0.05050 0.05186 0.07649 0.07815 0.07981 0.05013 0.05150 0.05287
0.5 0.07444 0.07608 0.07772 0.10769 0.10963 0.11157 0.07553 0.07718 0.07883
1 0.12564 0.12771 0.12978 0.16637 0.16869 0.17101 0.12670 0.12878 0.13086
2 0.22352 0.22611 0.22870 0.27454 0.27731 0.28008 0.22468 0.22728 0.22988
Table 6.4: Power with a 95% confidence interval for setting 2: X1j ∼ MV N(0, Σ),
X2j ∼ MV N(1, Σ), X3j ∼ MV N(1, Σ).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
ρ L center U L center U L center U
0 0.09062 0.09241 0.09420 0.09526 0.09710 0.09894 0.09089 0.09269 0.09449
0.25 0.12269 0.12474 0.12679 0.13017 0.13227 0.13437 0.12313 0.12518 0.12723
0.5 0.15300 0.15524 0.15748 0.16373 0.16604 0.16835 0.15362 0.15587 0.15812
1 0.20133 0.20383 0.20633 0.21803 0.22060 0.22317 0.20216 0.20466 0.20716
2 0.27657 0.27935 0.28213 0.30059 0.30344 0.30629 0.27753 0.28031 0.28309
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Table 6.5: Type I error with a 95% confidence interval for setting 3: X1j ∼
N(0, 10), X2j ∼ N(0, 10), X3j ∼ N(1, var).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
var L center U L center U L center U
8 0.00163 0.00190 0.00217 0.00395 0.00436 0.00477 0.00173 0.00201 0.00229
9 0.00230 0.00262 0.00294 0.00482 0.00527 0.00572 0.00237 0.00269 0.00301
10 0.00270 0.00304 0.00338 0.00520 0.00567 0.00614 0.00276 0.00311 0.00346
11 0.00314 0.00351 0.00388 0.00565 0.00613 0.00661 0.00327 0.00364 0.00401
12 0.00382 0.00422 0.00462 0.00638 0.00689 0.00740 0.00392 0.00433 0.00474
14 0.00567 0.00615 0.00663 0.00809 0.00866 0.00923 0.00575 0.00624 0.00673
16 0.00757 0.00813 0.00869 0.01034 0.01099 0.01164 0.00770 0.00826 0.00882
18 0.00906 0.00967 0.01028 0.01168 0.01237 0.01306 0.00917 0.00978 0.01039
20 0.01176 0.01245 0.01314 0.01441 0.01517 0.01593 0.01186 0.01255 0.01324
Table 6.6: Power with a 95% confidence interval for setting 3: X1j ∼ N(0, 10),
X2j ∼ N(0, 10), X3j ∼ N(1, var).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
var L center U L center U L center U
8 0.08688 0.08864 0.09040 0.08722 0.08898 0.09074 0.08691 0.08867 0.09043
9 0.09456 0.09639 0.09822 0.09497 0.09680 0.09863 0.09460 0.09643 0.09826
10 0.10002 0.10189 0.10376 0.10076 0.10264 0.10452 0.10007 0.10195 0.10383
11 0.10730 0.10923 0.11116 0.10806 0.11000 0.11194 0.10741 0.10934 0.11127
12 0.11142 0.11339 0.11536 0.11246 0.11443 0.11640 0.11151 0.11348 0.11545
14 0.12331 0.12536 0.12741 0.12465 0.12671 0.12877 0.12335 0.12540 0.12745
16 0.13456 0.13669 0.13882 0.13633 0.13847 0.14061 0.13462 0.13675 0.13888
18 0.14392 0.14611 0.14830 0.14640 0.14860 0.15080 0.14403 0.14622 0.14841
20 0.15158 0.15382 0.15606 0.15440 0.15665 0.15890 0.15169 0.15393 0.15617
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Table 6.7: Type I error with a 95% confidence interval for setting 4: X1j ∼
N(0, 10), X2j ∼ N(1, var), X3j ∼ N(1, var).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
var L center U L center U L center U
8 0.01393 0.01468 0.01543 0.02989 0.03096 0.03203 0.01438 0.01514 0.01590
9 0.02077 0.02167 0.02257 0.03962 0.04085 0.04208 0.02159 0.02251 0.02343
10 0.02714 0.02817 0.02920 0.04857 0.04992 0.05127 0.02793 0.02897 0.03001
11 0.03626 0.03744 0.03862 0.05926 0.06074 0.06222 0.03706 0.03825 0.03944
12 0.04464 0.04594 0.04724 0.06954 0.07113 0.07272 0.04575 0.04706 0.04837
14 0.06310 0.06462 0.06614 0.09102 0.09282 0.09462 0.06413 0.06567 0.06721
16 0.08361 0.08534 0.08707 0.11595 0.11795 0.11995 0.08487 0.08661 0.08835
18 0.10277 0.10467 0.10657 0.13608 0.13822 0.14036 0.10384 0.10575 0.10766
20 0.11933 0.12135 0.12337 0.15494 0.15720 0.15946 0.12060 0.12263 0.12466
Table 6.8: Power with a 95% confidence interval for setting 4: X1j ∼ N(0, 10),
X2j ∼ N(1, var), X3j ∼ N(1, var).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
var L center U L center U L center U
8 0.07303 0.07466 0.07629 0.07537 0.07702 0.07867 0.07326 0.07489 0.07652
9 0.08339 0.08512 0.08685 0.08678 0.08854 0.09030 0.08371 0.08544 0.08717
10 0.09062 0.09241 0.09420 0.09526 0.09710 0.09894 0.09089 0.09269 0.09449
11 0.09906 0.10093 0.10280 0.10516 0.10708 0.10900 0.09944 0.10131 0.10318
12 0.10786 0.10980 0.11174 0.11526 0.11725 0.11924 0.10842 0.11036 0.11230
14 0.12423 0.12629 0.12835 0.13498 0.13711 0.13924 0.12488 0.12694 0.12900
16 0.14260 0.14478 0.14696 0.15727 0.15954 0.16181 0.14338 0.14557 0.14776
18 0.15824 0.16052 0.16280 0.17548 0.17785 0.18022 0.15925 0.16153 0.16381
20 0.17196 0.17431 0.17666 0.19131 0.19376 0.19621 0.17293 0.17529 0.17765
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Table 6.9: Type I error with a 95% confidence interval for setting 5: X1j ∼
N(0, 10), X2j ∼ N(0, 10), X3j ∼ Unif(0, 2).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
L center U L center U L center U
0.00004 0.00011 0.00018 0.00160 0.00187 0.00214 0.00005 0.00012 0.00019
Table 6.10: Power with a 95% confidence interval for setting 5: X1j ∼ N(0, 10),
X2j ∼ N(0, 10), X3j ∼ Unif(0, 2).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
L center U L center U L center U
0.03525 0.03641 0.03757 0.03525 0.03641 0.03757 0.03525 0.03641 0.03757
Table 6.11: Type I error with a 95% confidence interval for setting 6: X1j ∼
N(0, 10), X2j ∼ N(1, 10), X3j ∼ Unif(0, 2).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
L center U L center U L center U
0.00363 0.00402 0.00441 0.01543 0.01621 0.01699 0.00374 0.00414 0.00454
Table 6.12: Power with a 95% confidence interval for setting 6: X1j ∼ N(0, 10),
X2j ∼ N(1, 10), X3j ∼ Unif(0, 2).
standard d2 d2(δ) d2(X̄(3) − X̄(1))
L center U L center U L center U
0.05510 0.05653 0.05796 0.05521 0.05664 0.05807 0.05510 0.05653 0.05796
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Table 6.13: Type I error with a 95% confidence interval for setting 7: X1j ∼
N(−1, 10), X2j ∼ N(−1, 10), X3j ∼
√
10 · tdf .
standard d2 d2(δ) d2(X̄(3) − X̄(1))
df L center U L center U L center U
6 0.00673 0.00726 0.00779 0.00963 0.01025 0.01087 0.00682 0.00735 0.00788
9 0.00498 0.00544 0.00590 0.00771 0.00827 0.00883 0.00505 0.00551 0.00597
18 0.00333 0.00371 0.00409 0.00606 0.00656 0.00706 0.00344 0.00382 0.00420
27 0.00329 0.00366 0.00403 0.00613 0.00663 0.00713 0.00344 0.00382 0.00420
36 0.00311 0.00347 0.00383 0.00563 0.00611 0.00659 0.00321 0.00358 0.00395
45 0.00298 0.00334 0.00370 0.00535 0.00582 0.00629 0.00306 0.00342 0.00378
90 0.00285 0.00320 0.00355 0.00519 0.00565 0.00611 0.00289 0.00324 0.00359
180 0.00280 0.00315 0.00350 0.00553 0.00601 0.00649 0.00291 0.00326 0.00361
300 0.00262 0.00296 0.00330 0.00521 0.00568 0.00615 0.00270 0.00304 0.00338
Table 6.14: Power with a 95% confidence interval for setting 7: X1j ∼ N(−1, 10),
X2j ∼ N(−1, 10), X3j ∼
√
10 · tdf .
standard d2 d2(δ) d2(X̄(3) − X̄(1))
df L center U L center U L center U
6 0.12795 0.13003 0.13211 0.12965 0.13175 0.13385 0.12803 0.13012 0.13221
9 0.11869 0.12071 0.12273 0.11971 0.12174 0.12377 0.11874 0.12076 0.12278
18 0.10735 0.10928 0.11121 0.10808 0.11002 0.11196 0.10736 0.10929 0.11122
27 0.10470 0.10661 0.10852 0.10530 0.10722 0.10914 0.10474 0.10665 0.10856
36 0.10483 0.10674 0.10865 0.10553 0.10745 0.10937 0.10488 0.10679 0.10870
45 0.10157 0.10346 0.10535 0.10228 0.10417 0.10606 0.10164 0.10353 0.10542
90 0.10152 0.10341 0.10530 0.10225 0.10414 0.10603 0.10158 0.10347 0.10536
180 0.09951 0.10138 0.10325 0.10026 0.10214 0.10402 0.09956 0.10143 0.10330
300 0.10243 0.10432 0.10621 0.10312 0.10502 0.10692 0.10247 0.10436 0.10625
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Table 6.15: Type I error with a 95% confidence interval for setting 8: X1j ∼
N(−1, 10), X2j ∼
√
10 · tdf , X3j ∼
√
10 · tdf .
standard d2 d2(δ) d2(X̄(3) − X̄(1))
df L center U L center U L center U
6 0.07123 0.07284 0.07445 0.10078 0.10266 0.10454 0.07226 0.07388 0.07550
9 0.05287 0.05427 0.05567 0.07995 0.08165 0.08335 0.05387 0.05529 0.05671
18 0.03877 0.03998 0.04119 0.06258 0.06410 0.06562 0.03980 0.04103 0.04226
27 0.03487 0.03602 0.03717 0.05787 0.05933 0.06079 0.03576 0.03693 0.03810
36 0.03204 0.03315 0.03426 0.05426 0.05568 0.05710 0.03283 0.03395 0.03507
45 0.03114 0.03223 0.03332 0.05270 0.05410 0.05550 0.03187 0.03298 0.03409
90 0.02934 0.03040 0.03146 0.05004 0.05141 0.05278 0.03014 0.03122 0.03230
180 0.02797 0.02901 0.03005 0.04991 0.05128 0.05265 0.02885 0.02991 0.03097
300 0.02856 0.02961 0.03066 0.04935 0.05071 0.05207 0.02921 0.03027 0.03133
Table 6.16: Power with a 95% confidence interval for setting 8: X1j ∼ N(−1, 10),
X2j ∼
√
10 · tdf , X3j ∼
√
10 · tdf .
standard d2 d2(δ) d2(X̄(3) − X̄(1))
df L center U L center U L center U
6 0.13167 0.13378 0.13589 0.14359 0.14578 0.14797 0.13235 0.13446 0.13657
9 0.11627 0.11827 0.12027 0.12493 0.12699 0.12905 0.11677 0.11878 0.12079
18 0.10041 0.10229 0.10417 0.10660 0.10853 0.11046 0.10110 0.10298 0.10486
27 0.09805 0.09991 0.10177 0.10387 0.10578 0.10769 0.09852 0.10038 0.10224
36 0.09535 0.09719 0.09903 0.10065 0.10253 0.10441 0.09578 0.09762 0.09946
45 0.09463 0.09646 0.09829 0.10003 0.10191 0.10379 0.09513 0.09696 0.09879
90 0.09173 0.09353 0.09533 0.09666 0.09851 0.10036 0.09215 0.09396 0.09577
180 0.09174 0.09354 0.09534 0.09661 0.09846 0.10031 0.09204 0.09385 0.09566
300 0.09213 0.09394 0.09575 0.09685 0.09870 0.10055 0.09247 0.09428 0.09609
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CHAPTER VII
CONTRIBUTIONS AND FUTURE RESEARCH
DIRECTIONS
7.1 Contributions of the research
This research proposes two types of step-down procedures with inconstant thresholds
to solve the problem of discriminating three treatments. The new test procedures
employ sharper functions for d2 to enhance the chance of eliminating the less effective
treatments. The approaches can pick out a smaller subset of potentially the best
treatments than the procedure with constant thresholds.
The properties of P (error) are studied before introducing the new methodologies.
The proofs and the numerical results carried out in chapter 3 suggest that the setting
with two best treatments significantly determines the value of d2. Future study of
step-down procedure in the field of subset selection can concentrate on controlling
the error rate at the configuration of µ(1) ≤ µ(2) = µ(3).
There are several ways to formulate the probability of rejecting any best treatment.
The novelty of constructing P (error) in the manner presented in this thesis is that the
formulation uses as few integrals as possible. Especially, Pµ(1) ≤ µ(2) = µ(3)(error)
involves single integration in the restricted parameter space approach when the vari-
ance is known. The less integration is required, the faster the calculation is. The
equations formed in this research are sophisticated and easier to calculated.
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7.2 Future research directions
This section outlines a number of potential areas which can be extended from the
research started in the thesis.
• Study k > 3 case.
• Apply different functions to d2(X̄(3) − X̄(1)) in the step-down procedure with
feedback.
• Define an error decision or the power of a test procedure in a different way.
• Study subset selection procedures for the other types of data.
• Combine two methods.
The formulation of the d2 functions in the thesis are designed for comparing three
treatment means. The concept of constructing shorter thresholds for the step-down
procedure, however, can expand to multiple treatments. In a case with a large group
number, the formulation of P (error) becomes significantly complicated. Since an
error decision involves more scenarios, it requires multiple integration to describe
the error rate. The procedures presented in the thesis may not improve the power by
much when k > 3. Researchers might need to access the problem with high dimension
from a different point of view.
The step-down procedure with feedback applies an exponential function to d2(X̄(3)−
X̄(1)). The features of the function include having smaller values as the range of ob-
servation means gets shorter and converging to the constant d2 as the range goes to
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infinity. There are numerous functions possessing the same characteristics. One fu-
ture direction is to search for other functions of d2(X̄(3)− X̄(1)) which provide greater
improvement in power.
Type I error and the power of a test procedure can be defined in various ways
based on goals or the fields of interest. For example, experimenters may focus on
controlling the probability of accepting any inferior treatment and maximizing the
probability of identifying all of the best treatments. Although it is also a subset
selection problem, the set up is completely different. The subset selection problems
with varied goals can share the same idea of modifying the constant thresholds in the
step-down procedure.
This research studies continuous data. The unknown parameter of interest is the
mean of treatment. In some applications, the response may be binary or categorical
data, i.e. the patients with cancer live or die. It is also an interesting topic to
investigate subset selection procedure in different domain.
Last, it is possible to combine the advantages of the restricted parameter space
approach with the step-down procedure with feedback. In such way, power of a test
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